<SEC-DOCUMENT>0001193125-24-021029.txt : 20240131
<SEC-HEADER>0001193125-24-021029.hdr.sgml : 20240131
<ACCEPTANCE-DATETIME>20240131165011
ACCESSION NUMBER:		0001193125-24-021029
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20240131
DATE AS OF CHANGE:		20240131

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMERICAN SUPERCONDUCTOR CORP /DE/
		CENTRAL INDEX KEY:			0000880807
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTORS & GENERATORS [3621]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				042959321
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-253611
		FILM NUMBER:		24583668

	BUSINESS ADDRESS:	
		STREET 1:		SIXTY FOUR JACKSON ROAD
		CITY:			DEVENS
		STATE:			MA
		ZIP:			01434
		BUSINESS PHONE:		9788423000

	MAIL ADDRESS:	
		STREET 1:		SIXTY FOUR JACKSON ROAD
		CITY:			DEVENS
		STATE:			MA
		ZIP:			01434
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d719447d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to
Rule 424(b)(5)<BR>Registration No. 333-253611 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PRELIMINARY PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(To Prospectus dated June&nbsp;21, 2021) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>5,400,000 Shares </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g719447g79p77.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:32%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are offering 5,400,000
shares of our common stock. Our common stock is listed on The Nasdaq Global Select Market, or Nasdaq, under the symbol &#147;AMSC.&#148; On January&nbsp;30, 2024, the last reported sale price of our common stock was $13.44 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investing in our common stock involves a high degree of risk. Please read the information contained in and incorporated by reference under the heading
&#147;<A HREF="#supprom719447_4">Risk Factors</A>&#148; beginning on page S-4 of this prospectus supplement, and under similar headings in the other documents that are filed after the date hereof and incorporated by reference into this prospectus
supplement. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Price&nbsp;to&nbsp;the&nbsp;public</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting&nbsp;discounts&nbsp;and&nbsp;commissions&nbsp;(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,645,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds,&nbsp;before&nbsp;expenses,&nbsp;to&nbsp;us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,105,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:12.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:24%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For additional information about the expenses for which we have agreed to reimburse the underwriters in
connection with this offering, see &#147;Underwriting&#148; beginning on page S-15 of this prospectus supplement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have granted the
underwriters an option for a period of 30 days to purchase up to an additional 810,000 shares of our common stock at the public offering price, less underwriting discounts and commissions. Delivery of the shares of common stock is expected to be
made on or about February 2, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:32%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Sole Book-Running Manager </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Oppenheimer&nbsp;&amp; Co. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I></I></B><I>Co-Managers</I><B><I> </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Craig-Hallum</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Roth Capital Partners</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus supplement is January 30, 2024. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PROSPECTUS&nbsp;SUPPLEMENT </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_1">ABOUT&nbsp;THIS&nbsp;PROSPECTUS&nbsp;SUPPLEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-ii</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_2">WHERE&nbsp;YOU&nbsp;CAN&nbsp;FIND&nbsp;MORE&nbsp;INFORMATION;&nbsp;
INCORPORATION&nbsp;BY&nbsp;REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-iv</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_3">PROSPECTUS&nbsp;SUPPLEMENT&nbsp;SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_4">RISK&nbsp;FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_5">SPECIAL&nbsp;NOTE&nbsp;REGARDING&nbsp;FORWARD-LOOKING&nbsp;STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_6">USE&nbsp;OF&nbsp;PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-8</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_7">DIVIDEND&nbsp;POLICY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-9</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_8">DILUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-10</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_9"><FONT STYLE="white-space:nowrap">MATERIAL&nbsp;U.S.&nbsp;FEDERAL&nbsp;
INCOME&nbsp;TAX&nbsp;CONSEQUENCES&nbsp;TO&nbsp;NON-U.S.&nbsp;HOLDERS</FONT></A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-11</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_10">UNDERWRITING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-15</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_11">LEGAL&nbsp;MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-23</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">S-23</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PROSPECTUS </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_13">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_14">WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY
REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_15">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_16">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_17">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_18">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_19">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_20">DESCRIPTION OF OTHER SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_21">GLOBAL SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_22">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_23">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#supprom719447_24">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus relate to the offering of our common stock. Before buying any of the common stock that we are
offering, we urge you to carefully read this prospectus supplement and the accompanying prospectus, together with the information incorporated by reference as described under the heading &#147;Where You Can Find More Information; Incorporation by
Reference&#148; in this prospectus supplement. These documents contain important information that you should consider when making your investment decision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document is in two parts. The first part is this prospectus supplement, which describes the terms of this offering of common stock and also adds to and
updates information contained in the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus. The second part, the accompanying prospectus dated June&nbsp;21, 2021,
including the documents incorporated by reference therein, provides more general information. Generally, when we refer to this prospectus, we are referring to both parts of this document combined. To the extent there is a conflict between the
information contained in this prospectus supplement, on the one hand, and the information contained in the accompanying prospectus or in any document incorporated by reference that was filed with the Securities and Exchange Commission, or SEC,
before the date of this prospectus supplement, on the other hand, you should rely on the information in this prospectus supplement. If any statement in one of these documents is inconsistent with a statement in another document having a later date
&#150; for example, a document incorporated by reference in the accompanying prospectus &#150; the statement in the document having the later date modifies or supersedes the earlier statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained in or incorporated by reference in this prospectus supplement, the accompanying prospectus and in any free
writing prospectus that we have authorized for use in connection with this offering. Neither we nor any of the underwriters have authorized anyone to provide you with different information. If anyone provides you with different or inconsistent
information, you should not rely on it. We are not, and the underwriters are not, making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this
prospectus supplement, the accompanying prospectus, the documents incorporated by reference in this prospectus supplement and the accompanying prospectus, and in any free writing prospectus that we have authorized for use in connection with this
offering, is accurate only as of the date of those respective documents. Our business, financial condition, results of operations and prospects may have changed since those dates. You should read this prospectus supplement, the accompanying
prospectus, the documents incorporated by reference in this prospectus supplement and the accompanying prospectus, and any free writing prospectus that we have authorized for use in connection with this offering, in their entirety before making an
investment decision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, information contained in this prospectus supplement, the accompanying prospectus or the documents
incorporated by reference, concerning our industry and the markets in which we operate, including our general expectations and market position, market opportunity and market share, is based on information from our own management estimates and
research, as well as from industry and general publications and research, surveys and studies conducted by third parties. Management estimates are derived from publicly available information, our knowledge of our industry and assumptions based on
such information and knowledge, which we believe to be reasonable. In addition, assumptions and estimates of our and our industry&#146;s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors,
including those described in &#147;Risk Factors&#148; in this prospectus supplement, the accompanying prospectus and in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended March&nbsp;31, 2023, which are
incorporated by reference into this prospectus supplement. These and other important factors could cause our future performance to differ materially from our assumptions and estimates. See &#147;Special Note Regarding Forward-Looking
Statements.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">American Superconductor Corporation and our logo are two of our trademarks that are used in this prospectus supplement, the
accompanying prospectus and the documents incorporated by reference. This prospectus </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
supplement, the accompanying prospectus and the documents incorporated by reference also include trademarks, tradenames and service marks that are the property of other organizations. Solely for
convenience, trademarks and tradenames referred to in this prospectus supplement, the accompanying prospectus and the documents incorporated by reference appear without the <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> and <SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP> symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not
assert its rights, to these trademarks and tradenames. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When we refer to &#147;American Superconductor,&#148; &#147;we,&#148; &#147;our,&#148;
&#147;us&#148; and the &#147;Company&#148; in this prospectus, we mean American Superconductor Corporation, a Delaware corporation, and its consolidated subsidiaries, unless otherwise specified. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_2"></A>WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY
REFERENCE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Available Information </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We file
electronically reports, proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC.
The address of that website is <I>www.sec.gov</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our website address is <I>www.amsc.com</I>. The information contained in, or accessible through, our
website does not constitute a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus are part of a registration statement that we filed with the SEC and do not contain all of the
information in the registration statement. The full registration statement may be obtained from the SEC or us, as provided below. Other documents establishing the terms of the offered securities are or may be filed as exhibits to the registration
statement. Statements in this prospectus supplement and the accompanying prospectus about these documents are summaries and each statement is qualified in all respects by reference to the document to which it refers. You should refer to the actual
documents for a more complete description of the relevant matters. You may inspect a copy of the registration statement at the SEC&#146;s website, as provided above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Incorporation by Reference </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC&#146;s rules allow
us to &#147;incorporate by reference&#148; information into this prospectus supplement and the accompanying prospectus, which means that we can disclose important information to you by referring you to another document filed separately with the SEC.
The information incorporated by reference is deemed to be part of this prospectus supplement and the accompanying prospectus, and subsequent information that we file with the SEC will automatically update and supersede that information. Any
statement contained in a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus supplement and the accompanying prospectus to the extent that a statement contained in this
prospectus supplement or the accompanying prospectus modifies or replaces that statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus
incorporate by reference the following documents set forth below that we have previously filed with the SEC: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774923016265/amsc20230331_10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended March&nbsp;31, 2023, filed with the SEC on May&nbsp;31, 2023. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended June&nbsp;30,
2023, September&nbsp;30, 2023 and December&nbsp;31, 2023 filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774923022793/amsc20230630_10q.htm">August&nbsp;
9, 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774923029753/amsc20230930_10q.htm">November&nbsp;1, 2023</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774924002041/amsc20231231_10q.htm">January&nbsp;
24, 2024</A>, respectively. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The information specifically incorporated by reference into our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774923016265/amsc20230331_10k.htm">Form
 <FONT STYLE="white-space:nowrap">10-K</FONT></A> for the fiscal year ended March&nbsp;31, 2023 from our <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000119312523177510/d445502ddef14a.htm">Definitive Proxy Statement</A> on Schedule 14A,
filed with the SEC on June&nbsp;28, 2023. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000119312523171201/d497807d8k.htm">June&nbsp;21,
 2023</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774923023329/amsc20230811_8k.htm">August&nbsp;
11, 2023</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/880807/000119312524020938/d739219d8k.htm">January&nbsp;31, 2024</A>. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our common stock filed as <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774919011477/ex_146280.htm">Exhibit
 4.3</A> in our Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended March&nbsp;31, 2019, filed with the SEC on June&nbsp;5, 2019, and any other amendment or report filed with the SEC for the purpose of updating the
description. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We incorporate by reference into this prospectus supplement and accompanying prospectus all reports and other documents we
subsequently file with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-iv </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Exchange Act of 1934, as amended, between the date of this prospectus supplement and the termination of the offering of the securities described in this prospectus supplement. We are not,
however, incorporating by reference any documents or portions thereof, whether specifically listed above or filed in the future, that are not deemed &#147;filed&#148; with the SEC, including any information furnished pursuant to Items 2.02 or 7.01
of Form <FONT STYLE="white-space:nowrap">8-K</FONT> or related exhibits furnished pursuant to Item 9.01 of Form <FONT STYLE="white-space:nowrap">8-K.</FONT> The reports and documents specifically listed above or filed in the future (excluding any
information furnished to, rather than filed with, the SEC) are deemed to be part of this prospectus supplement and accompanying prospectus from the date of the filing of such reports and documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request a free copy of any of the documents incorporated by reference in this prospectus supplement by writing or telephoning us at the following
address and phone number: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>American Superconductor Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>114 East Main Street </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ayer, Massachusetts 01432 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Telephone: (978) <FONT STYLE="white-space:nowrap">842-3000</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Attention: Investor Relations </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibits to
the filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus supplement and the accompanying prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-v </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_3"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This summary highlights certain information about us, this offering and selected information contained elsewhere in or incorporated by reference into this
prospectus supplement or the accompanying prospectus. This summary is not complete and does not contain all of the information that you should consider before deciding whether to invest in our common stock. For a more complete understanding of our
company and this offering, we encourage you to read and consider carefully the more detailed information in this prospectus supplement and the accompanying prospectus, including the information incorporated by reference in this prospectus supplement
and the accompanying prospectus, and the information included in any free writing prospectus that we have authorized for use in connection with this offering, including the information under the heading &#147;Risk Factors&#148; in this prospectus
supplement on page <FONT STYLE="white-space:nowrap">S-4,</FONT> the financial statements and related notes and the risks discussed under &#147;Risk Factors&#148; in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the
fiscal year ended March&nbsp;31, 2023. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>American Superconductor Corporation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Company </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a leading system provider of
megawatt-scale power resiliency solutions that Orchestrate the Rhythm and Harmony of Power on the Grid, and protect and expand the capability of our Navy&#146;s fleet. Our solutions enhance the performance of the power grid, protect our Navy&#146;s
fleet, and lower the cost of wind power. In the power grid market, we enable electric utilities, industrial facilities, and renewable energy project developers to connect, transmit and distribute smarter, cleaner and better power through our
transmission planning services and power electronics and superconductor-based systems. In the wind power market, we enable manufacturers to field highly competitive wind turbines through our advanced power electronics and control system products,
engineering, and support services. Our power grid and wind products and services provide exceptional reliability, security, efficiency and affordability to our customers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our power system solutions help to improve energy efficiency, alleviate power grid capacity constraints, improve system resiliency, and increase the adoption
of renewable energy generation. Demand for our solutions is driven by the growing needs for modernized smart grids that improve power reliability, security and quality, the U.S. Navy&#146;s effort to upgrade
<FONT STYLE="white-space:nowrap">in-board</FONT> power systems to support fleet electrification, and the need for increased renewable sources of electricity, such as wind and solar energy. Concerns about these factors have led to increased spending
by corporations and the military, as well as supportive government regulations and initiatives on local, state, and national levels, including renewable portfolio standards, tax incentives and international treaties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We manufacture products using two proprietary core technologies: PowerModule programmable power electronic converters and our Amperium high temperature
superconductor wires. These technologies and our system-level solutions are protected by a broad and deep intellectual property portfolio consisting of hundreds of patents and licenses worldwide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We operate our business under two market-facing business units: Grid and Wind. We believe this market-centric structure enables us to more effectively
anticipate and meet the needs of power generation project developers, the Navy&#146;s ship protection systems, electric utilities and wind turbine manufacturers. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Grid</I>. Through our Gridtec Solutions, our Grid business segment enables electric utilities and renewable
energy project developers to connect, transmit and distribute power with exceptional efficiency, reliability, security and affordability. We provide transmission planning services that allow us to identify power grid congestion, poor power quality,
and other risks, which help us determine how our solutions can improve network performance. These services often lead to sales of our grid interconnection solutions for wind farms and solar power plants, power quality systems and transmission and
distribution cable systems. We also sell ship protection products to the U.S. Navy through our Grid business segment. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Wind</I>. Through our Windtec Solutions, our Wind business segment enables manufacturers to field wind
turbines with exceptional power output, reliability and affordability. We supply advanced power electronics and control systems, license our highly engineered wind turbine designs, and provide extensive customer support services to wind turbine
manufacturers. Our design portfolio includes a broad range of drivetrains and power ratings of 2 MW and higher. We provide a broad range of power electronics and software-based control systems that are highly integrated and designed for optimized
performance, efficiency, and grid compatibility. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Corporate Information </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were incorporated in the State of Delaware on April&nbsp;9, 1987. Our principal executive offices are located at 114 East Main Street, Ayer, Massachusetts
01432 and our telephone number is (978) <FONT STYLE="white-space:nowrap">842-3000.</FONT> Our website address is <I>www.amsc.com</I>. The information contained in, or accessible through, our website does not constitute a part of this prospectus
supplement. We have included our website address in this prospectus supplement solely as an inactive textual reference. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1px solid #000000;BORDER-LEFT:1px solid #000000;BORDER-RIGHT:1px solid #000000;BORDER-TOP:1px solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>The Offering </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by us </P></TD>
<TD>5,400,000 shares </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding immediately after this offering </P></TD>
<TD>36,136,347 shares (or 36,946,347 shares if the underwriters exercise in full their option to purchase additional shares) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Underwriters&#146; option to purchase additional shares </P></TD>
<TD>We have granted the underwriters an option to purchase up to 810,000 additional shares of our common stock. This option is exercisable, in whole or in part, for a period of 30 days from the date of this prospectus supplement. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We intend to use the net proceeds of this offering for working capital and general corporate purposes. Please see &#147;Use of Proceeds&#148; on page <FONT STYLE="white-space:nowrap">S-8.</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>See &#147;Risk Factors&#148; beginning on page <FONT STYLE="white-space:nowrap">S-4</FONT> of this prospectus supplement and in the documents incorporated by reference into this prospectus supplement, for a discussion of factors that you should
read and consider before investing in our common stock. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Nasdaq Global Select Market symbol </P></TD>
<TD>&#147;<I>AMSC</I>&#148; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Transfer Agent </P></TD>
<TD>Equiniti Trust Company, LLC </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares of our common stock to be outstanding immediately after this offering as shown above
is based on 30,736,347 shares outstanding as of December&nbsp;31, 2023, which includes 1,454,654 shares of restricted common stock that were subject to vesting restrictions as of such date and were not considered outstanding for accounting purposes,
and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">36,206 shares of common stock issuable upon the exercise of outstanding options, having a weighted average
exercise price of $6.94 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">246,644 shares of common stock reserved for future issuance under our 2022 Stock Incentive Plan, or the 2022
Stock Plan, 2007 Stock Incentive Plan, as amended, or the 2007 Stock Plan, our Amended and Restated 2007 Director Stock Plan, as amended, or the 2007 Director Plan, and our 2000 Employee Stock Purchase Plan, as amended, or the ESPP; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the additional 300,000 shares of our common stock to be issued upon the achievement of a specified revenue
objective in connection with the Stock Purchase Agreement dated October&nbsp;1, 2020, or the NEPSI Stock Purchase Agreement, with the sellers named therein. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, this prospectus supplement reflects and assumes the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise of the outstanding options described above; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise by the underwriters of their option to purchase additional shares of our common stock.
</P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. Before investing in our securities, you should consider carefully the risks described below,
together with the other information contained in this prospectus supplement, the accompanying prospectus or incorporated by reference herein or therein, including the risks and uncertainties discussed under &#147;Risk Factors&#148; in our Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended March&nbsp;31, 2023 and any subsequent Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Current Reports on Form <FONT
STYLE="white-space:nowrap">8-K,</FONT> as well as any amendments thereto reflected in subsequent filings with the SEC, each of which are incorporated by reference in this prospectus supplement, and all of the other information in this prospectus
supplement, including our financial statements and related notes incorporated by reference herein. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we
currently deem immaterial may also affect our operations. If any of the risks or uncertainties we have described occur, our business, financial condition, results of operations and future growth prospects could be materially and adversely affected.
In these circumstances, the market price of our common stock could decline, and you may lose all or part of your investment in the offered securities. Please also read carefully the section below entitled &#147;Special Note Regarding Forward-Looking
Statements.&#148; </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to this Offering </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Purchasers in this offering will experience immediate and substantial dilution in the book value of their investment. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The public offering price of our common stock is substantially higher than the net tangible book value per share of our common stock before giving effect to
this offering. Accordingly, if you purchase our common stock in this offering, you will incur immediate substantial dilution of approximately $<U></U>8.91 per share, representing the difference between the public offering price of $11.25 <U></U>per
share, and our as adjusted net tangible book value as of December&nbsp;31, 2023. Furthermore, if outstanding stock options are exercised, you could experience further dilution. See the section entitled &#147;Dilution&#148; below for a more detailed
illustration of the dilution you would incur if you participate in this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>A substantial number of shares of common stock may be sold in the
market following this offering, which may depress the market price for our common stock. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sales of a substantial number of shares of our common
stock in the public market following this offering could cause the market price of our common stock to decline. A substantial majority of the outstanding shares of our common stock are, and the shares of common stock sold in this offering will be,
freely tradable without restriction or further registration under the Securities Act of 1933, as amended, or the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have broad
discretion to determine how to use the funds raised in this offering, and may use them in ways that may not enhance our operating results or the price of our common stock. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our management will have broad discretion over the use of proceeds from this offering, and we could spend the proceeds from this offering in ways our
stockholders may not agree with or that do not yield a favorable return, if at all. We intend to use the net proceeds of this offering for working capital and general corporate purposes. However, our use of these proceeds may differ substantially
from our current plans. If we do not invest or apply the proceeds of this offering in ways that improve our operating results, we may fail to achieve expected financial results, which could cause our stock price to decline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>You may experience future dilution as a result of future equity offerings. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to raise additional capital, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable
for our common stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities in any other offering at a price per share that is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
less than the price per share paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price
per share at which we sell additional shares of our common stock, or securities convertible or exchangeable into common stock, in future transactions may be higher or lower than the price per share paid by investors in this offering. As of
December&nbsp;31, 2023, 246,644 shares of common stock were reserved for future issuance under our equity incentive plans and the ESPP. As of that date, there were also options outstanding to purchase 36,206 shares of our common stock. You will
incur additional dilution upon the grant of any shares under our equity incentive plans or the ESPP or upon exercise of any outstanding or subsequently issued stock options. In connection with this offering, we and each of our directors and
executive officers have entered into <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements with the underwriters. As a result of these <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements, approximately 1,652,575 shares (including shares
issuable upon exercise of options) are subject to a contractual restriction on resale through the date that is 90 days after the date of this prospectus supplement. The market price for shares of our common stock may decline if stockholders subject
to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements sell a substantial number of shares when the restrictions on resale lapse, or if the underwriters waive the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements and allow the
stockholders to sell some or all of their shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_5"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus supplement, the accompanying prospectus, the documents we have filed with the SEC that are incorporated by reference and any free writing
prospectus that we have authorized for use in connection with this offering contain &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Securities Exchange Act of 1934, as
amended, or the Exchange Act. These statements relate to future events or to our future operating or financial performance and involve known and unknown risks, uncertainties and other important factors which may cause our actual results, performance
or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our strategy, future plans, prospects and goals; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">addressable markets for our products and services; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">business momentum; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the anticipated benefits from our recent acquisitions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">functionality, performance and capabilities of our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approaching break-even; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">growth markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">power quality and control solutions positioning us for growth; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">industry and market opportunities for our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expected high growth in India for future wind installations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential revenue streams; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">customer demand; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">inflection points; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">growth drivers; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the use of proceeds from this offering. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some cases, you can identify forward-looking statements by terms such as &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;could,&#148;
&#147;would,&#148; &#147;expects,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;projects,&#148; &#147;predicts,&#148; &#147;potential&#148; and similar expressions intended to identify
forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these
forward-looking statements. We discuss many of these risks in greater detail under the heading &#147;Risk Factors&#148; on page <FONT STYLE="white-space:nowrap">S-4</FONT> of this prospectus supplement and in our SEC filings. Also, these
forward-looking statements represent our estimates and assumptions only as of the date of the document containing the applicable statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should
read this prospectus supplement, the accompanying prospectus, the documents we have filed with the SEC that are incorporated by reference and any free writing prospectus that we have authorized for use in connection with this offering completely and
with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements in the foregoing documents by these cautionary statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained, or incorporated by reference, in this prospectus supplement, the accompanying prospectus and any free
writing prospectus that we have authorized for use in connection with this offering. We and the underwriters for this offering have not authorized anyone to provide you with different information. The shares of common stock offered under this
prospectus supplement and the accompanying </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
prospectus are not being offered in any state where the offer is not permitted. You should not assume that the information contained in this prospectus supplement or the accompanying prospectus
is accurate as of any date other than the date on the front of this prospectus supplement or the accompanying prospectus, as applicable, or that any information incorporated by reference into this prospectus supplement or the accompanying prospectus
is accurate as of any date other than the date of the document so incorporated by reference. Unless required by law, we undertake no obligation to update or revise any forward-looking statements to reflect new information or future events or
developments. Thus, you should not assume that our silence over time means that actual events are bearing out as expressed or implied in such forward-looking statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate that the net proceeds from this offering, after deducting the underwriting discounts and commissions and estimated offering expenses payable by
us, will be approximately $<U></U>56.6&nbsp;million, or approximately $65.2&nbsp;<U></U>million, if the underwriters exercise their option to purchase additional shares in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds from this offering for working capital and general corporate purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not determined the amounts we plan to spend in any of the areas identified above or the timing of these expenditures. As a result, our management will
have broad discretion to allocate the net proceeds to us from this offering, and investors will be relying on the judgment of our management regarding the application of the proceeds from this offering. We reserve the right to change the use of
these proceeds as a result of certain contingencies. Pending use of the proceeds as described above, we intend to invest the net proceeds of this offering in short-term, interest-bearing, investment-grade securities or certificates of deposit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_7"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have never paid cash dividends on our common stock. We currently intend to retain earnings, if any, to fund the development and growth of our business and
do not anticipate paying cash dividends for the foreseeable future. Payment of future cash dividends, if any, will be at the discretion of our board of directors after taking into account various factors, including our financial condition, operating
results, current and anticipated cash needs and plans for expansion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_8"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you invest in our common stock in this public offering, your ownership interest will be immediately diluted to the extent of the difference between the
offering price per share and the as adjusted net tangible book value per share of our common stock immediately after this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of
December&nbsp;31, 2023, we had a net tangible book value of $28.0&nbsp;million, or $0.91 per share of common stock. Our net tangible book value per share represents total tangible assets less total liabilities, divided by the number of shares of
common stock outstanding at December&nbsp;31, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After giving effect to the issuance and sale by us of <U></U>5,400,000 shares of our common stock in
this offering at a public offering price of $<U></U>11.25 per share, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us, our as adjusted net tangible book value as of
December&nbsp;31, 2023 would have been approximately $84.6 <U></U>million, or approximately $<U></U>2.34 per share. This amount represents an immediate increase in net tangible book value of $<U></U>1.43 per share to our existing stockholders and an
immediate dilution in net tangible book value of approximately $8.91 per share to new investors purchasing shares of common stock in this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dilution per share to new investors is determined by subtracting as adjusted net tangible book value per share after this offering from the public offering
price per share paid by new investors. The following table illustrates this dilution on a per share basis: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net tangible book value per share as of December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in net tangible book value per share attributable to this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">As adjusted net tangible book value per share after this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to new investors participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares of our common stock to be outstanding immediately after this offering as shown above is based on
30,736,347 shares outstanding as of December&nbsp;31, 2023, which includes 1,454,654 shares of restricted common stock that were subject to vesting restrictions as of such date and were not considered outstanding for accounting purposes, and
excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">36,206 shares of common stock issuable upon the exercise of outstanding options, having a weighted average
exercise price of $6.94 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">246,644 shares of common stock reserved for future issuance under the 2022 Stock Plan, the 2007 Stock Plan, the
2007 Director Plan and the ESPP; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the additional 300,000 shares of our common stock to be issued upon the achievement of a specified revenue
objective in connection with the NEPSI Stock Purchase Agreement. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent that options outstanding as of December&nbsp;31, 2023
have been or may be exercised or other shares may be issued, investors purchasing our common stock in this offering may experience further dilution. In addition, we may choose to raise additional capital due to market conditions or strategic
considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities could
result in further dilution to our stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_9"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following discussion is a summary of the material U.S. federal income tax consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders (as
defined below) of the purchase, ownership and disposition of our common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate
and gift tax laws, and any applicable state, local or foreign tax laws are not discussed. This discussion is based on the United States Internal Revenue Code of 1986, as amended, or the Code, Treasury Regulations promulgated thereunder, judicial
decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service, or the IRS, in each case, as in effect as of the date of this offering. These authorities may change or be subject to differing interpretations.
Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder. We have not sought and will not seek any rulings from the IRS regarding the
matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to the discussion below regarding the tax consequences of the purchase, ownership and disposition of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discussion is limited to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders that hold our common stock as a &#147;capital asset&#148; within the
meaning of Section&nbsp;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s particular
circumstances, including the impact of the alternative minimum tax, the Medicare contribution tax on net investment income, or any item of gross income with respect to our common stock being taken into account in an &#147;applicable financial
statement&#148; (as defined in the Code). In addition, it does not address consequences relevant to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders subject to special rules, including, without limitation: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">U.S. expatriates and certain former citizens or long-term residents of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons holding our common stock as part of a hedge, straddle or other risk reduction strategy or as part of a
conversion transaction or other integrated investment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">banks, insurance companies, and other financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">real estate investment trusts or regulated investment companies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brokers, dealers or traders in securities or currencies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies,&#148; and corporations
that accumulate earnings to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income
tax purposes (and investors therein); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations or governmental organizations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons deemed to sell our common stock under the constructive sale provisions of the Code;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;qualified foreign pension funds&#148; as defined in Section&nbsp;897(1)(2) of the Code and entities all of
the interests of which are held by qualified foreign pension funds; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or otherwise
as compensation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plans. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) holds our common stock, the tax treatment of an owner of such
entity generally will depend on the tax status of the owner and the activities of the entity. Accordingly, such entities holding our common stock and the owners of such entities should consult their tax advisors regarding the U.S. federal income tax
consequences to them. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS DISCUSSION IS FOR INFORMATION PURPOSES ONLY AND IS NOT INTENDED AS LEGAL OR TAX ADVICE. INVESTORS
SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK ARISING UNDER THE
U.S. FEDERAL ESTATE OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Definition of a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a <FONT STYLE="white-space:nowrap">&#147;non-U.S.</FONT> holder&#148; is any beneficial owner of our common stock that is
neither a &#147;U.S. person&#148; nor an entity treated as a partnership for U.S. federal income tax purposes. A U.S. person is any person that, for U.S. federal income tax purposes, is or is treated as any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation created or organized under the laws of the United States, any state thereof, or the District of
Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust that (1)&nbsp;is subject to the primary supervision of a U.S. court and the control of one or more
United&nbsp;States persons (within the meaning of Section&nbsp;7701(a)(30) of the Code), or (2)&nbsp;has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Distributions </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described in the
section entitled &#147;Dividend Policy,&#148; we do not anticipate declaring or paying any dividends on our common stock in the foreseeable future. However, if we do make distributions of cash or property on our common stock, such distributions will
constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax
purposes will constitute a return of capital and first be applied against and reduce a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s adjusted tax basis in our common stock, but not below zero. Any excess will be treated as capital
gain and will be treated as described below under &#147;Sale or Other Taxable Disposition.&#148; Because we may not know the extent to which a distribution is a dividend for U.S. federal income tax purposes at the time it is made, for purposes of
the withholding rules discussed below we or the applicable withholding agent may treat the entire distribution as a dividend. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussion
below on effectively connected income, dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by
an applicable income tax treaty, provided the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder furnishes a valid IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or other applicable documentation) certifying qualification for such lower treaty rate). A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that does
not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS.
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding their entitlement to benefits under any applicable income tax treaty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder are effectively connected with the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder maintains a
permanent establishment in the United States to which such dividends are attributable), then the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be exempt from the U.S. federal withholding tax described above. To claim the exemption,
the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder must furnish to the applicable withholding agent a valid IRS Form <FONT STYLE="white-space:nowrap">W-8ECI,</FONT> certifying that the dividends are effectively connected with the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct of a trade or business within the United States. Any such effectively connected dividends will be subject to U.S. federal income tax on a net
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
income basis at the regular rates. In addition, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is a corporation may be subject to a branch profits tax at a rate of 30% (or such
lower rate specified by an applicable income tax treaty) on its effectively connected dividends, as adjusted for certain items. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding any applicable tax
treaties that may provide for different rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sale or Other Taxable Disposition </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussion below on backup withholding, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will not be subject to U.S. federal income
tax on any gain realized upon the sale or other taxable disposition of our common stock unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct
of a trade or business within the United&nbsp;States (and, if required by an applicable income tax treaty, the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder maintains a permanent establishment in the United States to which such gain is
attributable); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a nonresident alien individual present in the
United States for 183 days or more during the taxable year of the disposition and certain other requirements are met; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our common stock constitutes a U.S. real property interest, or USRPI, by reason of our status as a U.S. real
property holding corporation, or USRPHC, for U.S. federal income tax purposes. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Gain described in the first bullet point above will
generally be subject to U.S. federal income tax on a net income basis at the regular rates. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower
rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on any gain realized
upon the sale or other taxable disposition of our common stock, which may be offset by certain U.S. source capital losses of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder (even though the individual is not considered a resident of the
United States) provided the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder has timely filed U.S. federal income tax returns with respect to such losses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With respect to the third bullet point above, we believe we are not currently and do not anticipate becoming a USRPHC. Because the determination of whether we
are a USRPHC depends on the fair market value of our USRPIs relative to the fair market value of our other business assets and our <FONT STYLE="white-space:nowrap">non-U.S.</FONT> real property interests, however, there can be no assurance we are
currently not a USRPHC or will not become one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or other taxable disposition of our common stock by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will not
be subject to U.S. federal income tax if our common stock is &#147;regularly traded,&#148; as defined by applicable Treasury Regulations, on an established securities market, and such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder owned,
actually and constructively, 5% or less of our common stock throughout the shorter of the <FONT STYLE="white-space:nowrap">five-year</FONT> period ending on the date of the sale or other taxable disposition or the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period for such stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders
should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will not be subject to backup withholding with respect to payments of dividends on our common stock
we make to the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder, provided the applicable withholding agent does not have actual knowledge or reason to know such holder is a United States person and the holder certifies its <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> status, such as by providing a valid IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or <FONT
STYLE="white-space:nowrap">W-8ECI,</FONT> or otherwise establishes an exemption. However, information returns are required to be filed with the IRS in connection with any distributions on our common stock paid to the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder, regardless of whether such distributions constitute dividends or whether any tax was actually withheld. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, proceeds of the sale or other taxable disposition of our common stock within the United States
or conducted through certain U.S.-related brokers generally will not be subject to backup withholding or information reporting if the applicable withholding agent receives the certification described above and does not have actual knowledge or
reason to know that such holder is a United States person or the holder otherwise establishes an exemption. Proceeds of a disposition of our common stock conducted through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> broker generally will not be subject to backup withholding or information reporting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of information
returns that are filed with the IRS may also be made available under the provisions of a specific treaty or agreement to the tax authorities of the country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is
established. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a refund or a credit
against a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Additional Withholding Tax on Payments Made to Foreign Accounts </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Withholding taxes may be imposed under Sections 1471-1474 of the Code (such Sections commonly referred to as the Foreign Account Tax Compliance Act, or FATCA)
on certain types of payments made to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> financial institutions and certain other <FONT STYLE="white-space:nowrap">non-U.S.</FONT> entities. Specifically, a 30% withholding tax may be imposed on dividends
on, or (subject to the proposed Treasury Regulations discussed below) gross proceeds from the sale or other disposition of, our common stock paid to a &#147;foreign financial institution&#148; or a
<FONT STYLE="white-space:nowrap">&#147;non-financial</FONT> foreign entity&#148; (each as defined in the Code), unless (1)&nbsp;the foreign financial institution undertakes certain diligence and reporting obligations, (2)&nbsp;the <FONT
STYLE="white-space:nowrap">non-financial</FONT> foreign entity either certifies it does not have any &#147;substantial United&nbsp;States owners&#148; (as defined in the Code) or furnishes identifying information regarding each substantial
United&nbsp;States owner, or (3)&nbsp;the foreign financial institution or <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity otherwise qualifies for an exemption from these rules. If the payee is a foreign financial institution
and is subject to the diligence and reporting requirements in clause (1)&nbsp;above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertake to identify accounts held by certain
&#147;specified United States persons&#148; or &#147;United States owned foreign entities&#148; (each as defined in the Code), annually report certain information about such accounts, and withhold 30% on certain payments to <FONT
STYLE="white-space:nowrap">non-compliant</FONT> foreign financial institutions and certain other account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing FATCA
may be subject to different rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the applicable Treasury Regulations and administrative guidance, withholding under FATCA generally applies to
payments of dividends on our common stock. While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition of stock on or after January&nbsp;1, 2019, proposed Treasury Regulations eliminate
FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations are issued. Because we may not know the extent to which a distribution is a dividend for
U.S. federal income tax purposes at the time it is made, for purposes of these withholding rules we or the applicable withholding agent may treat the entire distribution as a dividend. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prospective investors should consult their tax advisors regarding the potential application of withholding under FATCA to their investment in our common
stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_10"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We entered into an underwriting agreement with the underwriters named below dated the date of this prospectus supplement. Oppenheimer&nbsp;&amp; Co. Inc. is
acting as the sole book-running manager and representative of the underwriters. The underwriting agreement provides for the purchase of a specific number of shares of common stock by each of the underwriters. The underwriters&#146; obligations are
several, which means that each underwriter is required to purchase a specified number of shares of common stock, but is not responsible for the commitment of any other underwriter to purchase shares of common stock. Subject to the terms and
conditions of the underwriting agreement, each underwriter has severally and not jointly agreed to purchase the number of shares of common stock set forth opposite its name below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>Shares&nbsp;of</B><br><B>Common</B><br><B>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Oppenheimer&nbsp;&amp; Co. Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,780,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Craig-Hallum Capital Group LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">810,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Roth Capital Partners, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">810,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions set forth in the underwriting agreement, the underwriters have agreed, severally and not
jointly, to purchase all of the shares offered by this prospectus supplement (other than those covered by the option described below), if any are purchased. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares of common stock offered hereby are expected to be ready for delivery on or about February 2, 2024 against payment in immediately available funds.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters are offering the shares of common stock subject to various conditions and may reject all or part of any order. The representative of the
underwriters has advised us that the underwriters propose initially to offer the shares of common stock to the public at the public offering price set forth on the cover page of this prospectus supplement and to dealers at a price less a concession
not in excess of $0.405 per share of common stock to brokers and dealers. After the shares of common stock are released for sale to the public, the representative may change the offering price, the concession, and other selling terms at various
times. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have granted the underwriters an option to purchase additional shares for the purpose of covering over-allotments. This option, which is
exercisable for up to 30 days after the date of this prospectus supplement, permits the underwriters to purchase a maximum of additional shares of common stock from us. If the underwriters exercise all or part of this option, they will purchase
shares of common stock covered by the option at the public offering price that appears on the cover page of this prospectus supplement, less the underwriting discounts and commissions. The underwriters have severally agreed that, to the extent the
option is exercised, they will each purchase a number of additional shares proportionate to such underwriter&#146;s initial amount reflected in the foregoing table. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the amount of the discounts and commissions to be paid to the underwriters by us, before expenses: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Per</B><br><B>Share&nbsp;of</B><br><B>Common</B><br><B>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total&nbsp;Without&nbsp;Exercise&nbsp;of</B><br><B>Underwriters&#146;&nbsp;Option</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total&nbsp;With&nbsp;Full&nbsp;Exercise&nbsp;of</B><br><B>Underwriters&#146;&nbsp;Option</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69,862,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and commissions(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,645,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,191,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,105,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,670,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:12.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:24%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">We have agreed to pay the underwriters a commission of 6.0% of the gross proceeds of this offering.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate that our total expenses of the offering, excluding the estimated underwriting discounts and
commissions, will be approximately $400,000. We have agreed to reimburse the underwriters up to $75,000 for all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incident to
the performance of the obligations of the representative under the underwriting agreement (including, without limitation, the fees and expenses of the underwriters&#146; outside attorneys). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have agreed not to directly or indirectly offer, sell (including, without limitation, any short sale), assign, transfer, pledge, contract to sell,
establish an open &#147;put equivalent position&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">16a-1(h)</FONT> under the Exchange Act, or otherwise dispose of, or announce the offering of, or file any registration statement under
the Securities Act in respect of, any shares of our common stock, options, rights or warrants to acquire shares of our common stock or securities exchangeable or exercisable for or convertible into shares of our common stock (other than is
contemplated by the underwriting agreement) or publicly announce any intention to do any of the foregoing, without the prior written consent of Oppenheimer&nbsp;&amp; Co. Inc. for a period of 90 days after the date of the final prospectus supplement
for this offering; provided, however, that we may (i)&nbsp;issue shares of our common stock and options to purchase shares of our common stock, shares of our common stock underlying options granted and other securities, each pursuant to any
disclosed director or employee benefits plan, stock incentive plan, stock ownership plan or dividend reinvestment plan of the company in effect on the date of the final prospectus supplement for this offering; (ii)&nbsp;issue shares of our common
stock pursuant to the conversion of securities or the exercise of warrants, which securities or warrants are disclosed and outstanding on the date of the final prospectus supplement for this offering; (iii)&nbsp;adopt a new equity incentive plan,
and file a registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act to register the offer and sale of securities to be issued pursuant to such new equity incentive plan, and issue securities pursuant to
such new equity incentive plan (including, without limitation, the issuance of shares of our common stock upon the exercise of options or other securities issued pursuant to such new equity incentive plan), provided that (1)&nbsp;such new equity
incentive plan satisfies the transaction requirements of General Instruction A.1 of Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act and (2)&nbsp;this clause (iii)&nbsp;shall not be available unless each recipient of shares
of our common stock, or securities exchangeable or exercisable for or convertible into shares of our common stock, pursuant to such new equity incentive plan shall be contractually prohibited from selling, offering, disposing of or otherwise
transferring any such shares or securities during the remainder of the <FONT STYLE="white-space:nowrap">lock-up</FONT> period; and (iv)&nbsp;issue shares of common stock, or securities exchangeable or exercisable for or convertible into common
stock, in connection with a transaction with an unaffiliated third party on an arm&#146;s length basis that includes a <I>bona fide</I> commercial relationship (including joint ventures, marketing or distribution arrangements, collaboration
agreements or intellectual property license agreements) or any acquisition of assets or not less than a majority or controlling portion of the equity of another entity, provided that the aggregate number of shares issued pursuant to this clause
(iv)&nbsp;shall not exceed ten percent (10%) of the total number of outstanding shares of common stock immediately following the issuance and sale of the shares of common stock in this offering. In addition, we will cause each <FONT
STYLE="white-space:nowrap">lock-up</FONT> party to furnish to Oppenheimer&nbsp;&amp; Co. Inc., prior to the closing date of this offering, a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our directors and executive officers have entered into <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements with the underwriters pursuant to which each
of these persons, with limited exceptions, for a period of 90 days after the date of the final prospectus supplement for this offering, may not, without the prior written consent of Oppenheimer&nbsp;&amp; Co. Inc., directly or indirectly,
(i)&nbsp;offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose of, or announce the intention to otherwise dispose of, any shares of our common stock (including, without limitation, shares of our common stock which may be
deemed to be beneficially owned by the undersigned in accordance with the rules and regulations promulgated under the Securities Act, as the same may be amended or supplemented from time to time (such shares, the &#147;Beneficially Owned
Shares&#148;)) or securities convertible into or exercisable or exchangeable for shares of our common stock, (ii)&nbsp;enter into any swap, hedge or similar agreement or arrangement that transfers in whole or in part, the economic risk of ownership
of the Beneficially Owned Shares or securities convertible into or exercisable or exchangeable for shares of our common stock, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition, or (iii)&nbsp;engage in any short selling
of shares of our common stock or securities convertible into or exercisable or exchangeable for shares of our common stock, in each case other than: (1)&nbsp;any transfers made by the <FONT STYLE="white-space:nowrap">lock-up</FONT> party (a)&nbsp;as
a bona fide gift to any member of the immediate family of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or to a trust the beneficiaries of which are exclusively the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or members of the <FONT
STYLE="white-space:nowrap">lock-up</FONT> party&#146;s immediate family, (b)&nbsp;by will or intestate succession upon the death of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or (c)&nbsp;as a bona fide gift to a charity or educational
institution, (2)&nbsp;transactions relating to shares of our common stock or other securities convertible into or exercisable or exchangeable for shares of our common stock acquired in open market transactions after completion of this offering,
provided that no such transaction is required to be, or is, publicly announced (whether on Form 4, Form 5 or otherwise) during the <FONT STYLE="white-space:nowrap">lock-up</FONT> period, (3)&nbsp;the entry, by the
<FONT STYLE="white-space:nowrap">lock-up</FONT> party, at any time on or after the date of the underwriting agreement, of any trading plan providing for the sale of shares of our common stock by the <FONT STYLE="white-space:nowrap">lock-up</FONT>
party, which trading plan meets the requirements of Rule <FONT STYLE="white-space:nowrap">10b5-1(c)</FONT> under the Exchange Act (a <FONT STYLE="white-space:nowrap">&#147;10b5-1</FONT> Plan&#148;), provided, however, that such plan does not provide
for, or permit, the sale of any shares of our common stock during the <FONT STYLE="white-space:nowrap">lock-up</FONT> period and no public announcement or filing is voluntarily made or required regarding such plan during the <FONT
STYLE="white-space:nowrap">lock-up</FONT> period, (4)&nbsp;transfers pursuant to a <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan established prior to the date of the final prospectus supplement for this offering for the transfer of shares of
our common stock of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party, a copy of which has been provided to the underwriters prior to the date of the final prospectus supplement for this offering, provided, that no public filing, report or
announcement shall be voluntarily made, and that any filing required to be made under the Exchange Act during the <FONT STYLE="white-space:nowrap">lock-up</FONT> period in connection with such a transfer shall disclose that such transfer was made
pursuant to a <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan entered into on a date before the date of the underwriting agreement, (5)&nbsp;any transfer pursuant to a domestic relations order or negotiated divorce settlement or otherwise by
operation of law, (6)&nbsp;any transfers made by the <FONT STYLE="white-space:nowrap">lock-up</FONT> party to us to satisfy tax withholding obligations pursuant to the our disclosed equity incentive plans or arrangements or to pay the exercise price
of any options issued under any such plan or arrangement which expires during the <FONT STYLE="white-space:nowrap">lock-up</FONT> period, provided, that any report under Section&nbsp;16(a) of the Exchange Act in connection with such transfer shall
indicate, to the extent permitted by Section&nbsp;16(a) of the Exchange Act and the related rules and regulations, the reason for such disposition and that such transfer of common stock was solely to us, and (7)&nbsp;any transfers in connection with
a bona fide third party tender offer, merger, consolidation or other similar transaction made to all holders of our common stock involving a change of our control, provided that in the event that the tender offer, merger, consolidation or other such
transaction is not completed, the shares of our common stock held by the <FONT STYLE="white-space:nowrap">lock-up</FONT> party shall remain subject to the restrictions contained in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement;
provided, however, that in the case of any transfer described in clauses (1)&nbsp;and (5) above, it shall be a condition to the transfer that (A)&nbsp;the transferee executes and delivers to Oppenheimer&nbsp;&amp; Co. Inc., acting on behalf of the
underwriters, not later than one business day prior to such transfer, a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement (it being understood that any references to &#147;immediate family&#148; in the
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreement shall expressly refer only to the immediate family of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party and not to the immediate family of the transferee) and otherwise satisfactory
in form and substance to Oppenheimer&nbsp;&amp; Co. Inc., and (B)&nbsp;no filing by any party under the Exchange Act or other public announcement shall be required or shall be made voluntarily in connection with such transfer, and the undersigned is
required to file a report under Section&nbsp;16(a) of the Exchange Act reporting a reduction in beneficial ownership of shares of our common stock or Beneficially Owned Shares or any securities convertible into or exercisable or exchangeable for
shares of our common stock or Beneficially Owned Shares during the <FONT STYLE="white-space:nowrap">lock-up</FONT> period (as the same may be extended as described above), the <FONT STYLE="white-space:nowrap">lock-up</FONT> party shall clearly
indicate in the footnotes to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement that (a)&nbsp;the filing relates to the circumstances described as appropriate in clause (1)&nbsp;or (5) and (b)&nbsp;no shares were sold by the reporting
person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rules of the SEC may limit the ability of the underwriters to bid for or purchase shares of common stock before the distribution of the shares is
completed. However, the underwriters may engage in the following activities in accordance with the rules: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Stabilizing transactions &#150; the representative may make bids or purchases for the purpose of pegging, fixing
or maintaining the price of the common stock, so long as stabilizing bids do not exceed a specified maximum. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Over-allotments and syndicate covering transactions &#150; the underwriters may sell more shares of common stock
in connection with this offering than the number of shares of common stock that they have committed to purchase. This over-allotment creates a short position for the underwriters. This short sales position may involve either &#147;covered&#148;
short sales or &#147;naked&#148; short sales. Covered short sales are short sales made in an amount not greater than the underwriters&#146; over-allotment option to purchase additional shares of common stock in this offering described above. The
underwriters may close out any covered short position either by exercising its over-allotment option or by purchasing shares of common stock in the open market. To determine how they will close the covered short position, the underwriters will
consider, among other things, the price per share of common stock available for purchase in the open market, as compared to the price at which they may purchase shares of common stock through the over-allotment option. Naked short sales are short
sales in excess of the over-allotment option. The underwriters must close out any naked short position by purchasing shares of common stock in the open market. A naked short position is more likely to be created if the underwriters are concerned
that, in the open market after pricing, there may be downward pressure on the price per share of common stock that could adversely affect investors who purchase shares of common stock in this offering. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Penalty bids &#150; if the representative purchases shares of common stock in the open market in a stabilizing
transaction or syndicate covering transaction, it may reclaim a selling concession from the underwriters and selling group members who sold those shares of common stock as part of this offering. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Passive market making &#150; market makers in the common stock who are underwriters or prospective underwriters
may make bids for or purchases of shares of common stock, subject to limitations, until the time, if ever, at which a stabilizing bid is made. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Similar to other purchase transactions, the underwriters&#146; purchases to cover the syndicate short sales or to stabilize the market price of our common
stock may have the effect of raising or maintaining the market price of our common stock or preventing or mitigating a decline in the market price of our common stock. As a result, the price of our common stock may be higher than the price that
might otherwise exist in the open market. The imposition of a penalty bid might also have an effect on the price of the common stock if it discourages resales of our shares of common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither we nor the underwriters make any representation or prediction as to the effect that the transactions described above may have on the price of our
common stock. These transactions may occur on The Nasdaq Global Select Market or otherwise. If such transactions are commenced, they may be discontinued without notice at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Electronic Delivery of Prospectus Supplements</I>: A prospectus supplement in electronic format may be delivered to potential investors by one or more of
the underwriters participating in this offering. The prospectus supplement in electronic format will be identical to the paper version of such prospectus supplement. Other than the prospectus supplement in electronic format, the information on any
underwriter&#146;s website and any information contained in any other website maintained by an underwriter is not part of this prospectus supplement or the registration statement of which this prospectus supplement forms a part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include securities trading,
commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters and their respective affiliates have, from time to
time, performed, and may in the future perform, various financial advisory and investment banking services for us, for which they received or will receive customary fees and expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of
investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers and may at any time hold long and short
positions in such securities and instruments. Such investment and securities activities may involve securities and instruments of ours or our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
affiliates. The underwriters and their respective affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or
instruments and may at any time hold, or recommend to clients that they acquire, long or short positions in such securities and instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Investors </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>European Economic Area </I></P>
<P STYLE="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In relation to each Member State of the European Economic Area (each, a &#147;Relevant State&#148;), no shares of common stock have been offered or will be
offered pursuant to this offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares of common stock which has been approved by the competent authority in that Relevant State or, where
appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation), except that shares of common stock may be offered to the public in that Relevant State
at any time under the following exemptions under the Prospectus Regulation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under the Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus
Regulation), subject to obtaining the prior consent of the representative for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares of common stock shall require the issuer or the representative to publish a prospectus pursuant to Article 3 of the
Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each person in a Relevant State who initially
acquires any shares of common stock or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with us and the representative that it is a qualified investor within the meaning of the Prospectus Regulation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the case of any shares of common stock being offered to a financial intermediary as that term is used in Article 5(1) of the Prospectus Regulation, each
such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares of common stock acquired by it in the offer have not been acquired on a <FONT STYLE="white-space:nowrap">non-discretionary</FONT> basis on behalf
of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or resale in a Relevant State to qualified investors, in circumstances in which
the prior consent of the representative has been obtained to each such proposed offer or resale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We, the representative and each of our and the
representative&#146;s respective affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For
the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to the shares of common stock in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the
offer and any shares of common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of common stock, and the expression &#147;Prospectus Regulation&#148; means Regulation (EU) 2017/1129 (as amended). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The above selling restriction is in addition to the other selling restrictions set out below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the offering, the underwriters are not acting for anyone other than the issuer and will not be responsible to anyone other than the issuer
for providing the protections afforded to their clients nor for providing advice in relation to the offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>United Kingdom </I></P>
<P STYLE="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In relation to the United Kingdom, or the UK, no shares of common stock have been offered or will be offered pursuant to this offering to the public in the UK
prior to the publication of a prospectus in relation to the shares of common stock which is to be treated as if it had been approved by the Financial Conduct Authority in accordance with the transitional provisions in Article 74 (transitional
provisions) of the Prospectus Amendment etc (EU Exit) Regulations 2019/1234, except that the shares of common stock may be offered to the public in the United Kingdom at any time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">D.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under Article 2 of the UK Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">E.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the UK
Prospectus Regulation), subject to obtaining the prior consent of the representative for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">F.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Section&nbsp;86 of the Financial Services and Markets Act 2000
(&#147;FSMA&#148;), </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares of common stock shall require us or the representative to publish a
prospectus pursuant to Section&nbsp;85 of the FSMA or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of
this provision, the expression an &#147;offer to the public&#148; in relation to the shares of common stock in the United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offer and any shares
of common stock to be offered so as to enable an investor to decide to purchase or subscribe for any shares of common stock, and the expression &#147;UK Prospectus Regulation&#148; means Regulation (EU) 2017/1129 as it forms part of domestic law by
virtue of the European Union (Withdrawal) Act 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Canada </I></P>
<P STYLE="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument
<FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument <FONT STYLE="white-space:nowrap">31-103</FONT> Registration
Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus
supplement (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#146;s
province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or consult with a legal advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT> Underwriting Conflicts (NI 33 105), the underwriters are not
required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Israel </I></P> <P STYLE="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the State of Israel, this
prospectus supplement shall not be regarded as an offer to the public to purchase shares of common stock under the Israeli Securities Law, 5728 &#150; 1968, which requires a prospectus to be published and authorized by the Israel Securities
Authority, if it complies with certain provisions of Section&nbsp;15 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the Israeli Securities Law, 5728 &#150; 1968, including, inter alia, if: (i)&nbsp;the offer is made, distributed or directed to not more than 35 investors, subject to certain conditions (the
&#147;Addressed Investors&#148;); or (ii)&nbsp;the offer is made, distributed or directed to certain qualified investors defined in the First Addendum of the Israeli Securities Law, 5728 &#150;1968, subject to certain conditions (the &#147;Qualified
Investors&#148;). The Qualified Investors shall not be taken into account in the count of the Addressed Investors and may be offered to purchase securities in addition to the 35 Addressed Investors. The company has not and will not take any action
that would require it to publish a prospectus in accordance with and subject to the Israeli Securities Law, 5728 &#150; 1968. We have not and will not distribute this prospectus supplement or make, distribute or direct an offer to subscribe for our
common stock to any person within the State of Israel, other than to Qualified Investors and up to 35 Addressed Investors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Qualified Investors may have
to submit written evidence that they meet the definitions set out in of the First Addendum to the Israeli Securities Law, 5728 &#150; 1968. In particular, we may request, as a condition to be offered common stock, that Qualified Investors will each
represent, warrant and certify to us and/or to anyone acting on our behalf: (i)&nbsp;that it is an investor falling within one of the categories listed in the First Addendum to the Israeli Securities Law, 5728 &#150; 1968; (ii) which of the
categories listed in the First Addendum to the Israeli Securities Law, 5728 &#150; 1968 regarding Qualified Investors is applicable to it; (iii)&nbsp;that it will abide by all provisions set forth in the Israeli Securities Law, 5728 &#150; 1968 and
the regulations promulgated thereunder in connection with the offer to be issued common stock; (iv)&nbsp;that the shares of common stock that it will be issued are, subject to exemptions available under the Israeli Securities Law, 5728 &#150; 1968:
(a) for its own account; (b)&nbsp;for investment purposes only; and (c)&nbsp;not issued with a view to resale within the State of Israel, other than in accordance with the provisions of the Israeli Securities Law, 5728 &#150; 1968; and (v)&nbsp;that
it is willing to provide further evidence of its Qualified Investor status. Addressed Investors may have to submit written evidence in respect of their identity and may have to sign and submit a declaration containing, inter alia, the Addressed
Investor&#146;s name, address and passport number or Israeli identification number. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not authorized and do not authorize the making of any offer
of securities through any financial intermediary on our behalf, other than offers made by the underwriters and their respective affiliates, with a view to the final placement of the securities as contemplated in this document. Accordingly, no
purchaser of the shares, other than the underwriters, is authorized to make any further offer of shares on our behalf or on behalf of the underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Switzerland </I></P> <P STYLE="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares may not be
publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#147;SIX&#148;) or on any other stock exchange or regulated trading facility in Switzerland. This document does not constitute a prospectus within the meaning of, and
has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or
the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the shares or the offering may be publicly distributed or otherwise made
publicly available in Switzerland. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither this document nor any other offering or marketing material relating to the offering, the Company or the shares
have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares will not be supervised by, the Swiss Financial Market Supervisory Authority
(&#147;FINMA&#148;), and the offer of shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#147;CISA&#148;). The investor protection afforded to acquirers of interests in collective investment
schemes under the CISA does not extend to acquirers of shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Hong Kong </I></P>
<P STYLE="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No shares have been offered or sold, and no shares may be offered or sold, in Hong Kong, by means of any document, other than to persons whose ordinary
business is to buy or sell shares or debentures, whether as principal or agent; or to &#147;professional investors&#148; as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong, or SFO, and any rules made under that Ordinance; or
in other circumstances which do not result in the document being a &#147;prospectus&#148; as defined in the Companies Ordinance (Cap. 32) of Hong Kong (&#147;CO&#148;) or which do not constitute an offer or invitation to the public for the purpose
of the CO or the SFO. No document, invitation or advertisement relating to the shares has been issued or may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is
directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted under the securities laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to
persons outside Hong Kong or only to &#147;professional investors&#148; as defined in the SFO and any rules made under that Ordinance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus
supplement has not been registered with the Registrar of Companies in Hong Kong. Accordingly, this prospectus supplement may not be issued, circulated or distributed in Hong Kong, and the shares may not be offered for subscription to members of the
public in Hong Kong. Each person acquiring the shares will be required, and is deemed by the acquisition of the shares, to confirm that he is aware of the restriction on offers of the shares described in this prospectus supplement and the relevant
offering documents and that he is not acquiring, and has not been offered any shares in circumstances that contravene any such restrictions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_11"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins LLP will pass upon certain legal matters relating to the issuance and sale of the securities offered hereby on behalf of American
Superconductor Corporation. The underwriters are being represented in connection with this offering by White&nbsp;&amp; Case LLP, New York, New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_12"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of American Superconductor Corporation as of March&nbsp;31, 2023 and 2022 and for each of the years in the <FONT
STYLE="white-space:nowrap">two-year</FONT> period ended March&nbsp;31, 2023 and the effectiveness of internal control over financial reporting as of March&nbsp;31, 2023 incorporated in this Prospectus Supplement by reference from the American
Superconductor Corporation Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended March&nbsp;31, 2023, have been audited by RSM US LLP, an independent registered public accounting firm, as stated in their
reports thereon incorporated herein by reference, and have been incorporated in this Prospectus Supplement in reliance upon such reports and upon the authority of such firm as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>$250,000,000 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g719447g79p77.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>American Superconductor Corporation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Debt
Securities </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Warrants </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Units </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may offer and sell up to
$250,000,000 in the aggregate of the securities identified above from time to time in one or more offerings. This prospectus provides you with a general description of the securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each time we offer and sell securities, we will provide a supplement to this prospectus that contains specific information about the offering and the amounts,
prices and terms of the securities. The supplement may also add, update or change information contained in this prospectus with respect to that offering. You should carefully read this prospectus and the applicable prospectus supplement before you
invest in any of our securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may offer and sell the securities described in this prospectus and any prospectus supplement to or through one or
more underwriters, dealers and agents, or directly to purchasers, or through a combination of these methods. If any underwriters, dealers or agents are involved in the sale of any of the securities, their names and any applicable purchase price,
fee, commission or discount arrangement between or among them will be set forth, or will be calculable from the information set forth, in the applicable prospectus supplement. See the sections of this prospectus entitled &#147;About this
Prospectus&#148; and &#147;Plan of Distribution&#148; for more information. No securities may be sold without delivery of this prospectus and the applicable prospectus supplement describing the method and terms of the offering of such securities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>INVESTING IN OUR SECURITIES INVOLVES RISKS. SEE THE &#147;<U><A HREF="#toc719447_4">RISK FACTORS</A></U>&#148; ON PAGE 4 OF THIS PROSPECTUS AND ANY
SIMILAR SECTION CONTAINED IN THE APPLICABLE PROSPECTUS SUPPLEMENT CONCERNING FACTORS YOU SHOULD CONSIDER BEFORE INVESTING IN OUR SECURITIES. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
common stock is listed on The Nasdaq Global Select Market under the symbol &#147;AMSC.&#148; On June&nbsp;1, 2021, the last reported sale price of our common stock on The Nasdaq Global Select Market was $15.06 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the
adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is
June&nbsp;21, 2021. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_1">ABOUT THIS PROSPECTUS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_2">WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY
REFERENCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_3">THE COMPANY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_6">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_7">DESCRIPTION OF DEBT SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_8">DESCRIPTION OF OTHER SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_9">GLOBAL SECURITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_10">PLAN OF DISTRIBUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_11">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc719447_12">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_13"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission, or the SEC, using a &#147;shelf&#148;
registration process. By using a shelf registration statement, we may sell securities from time to time and in one or more offerings up to a total dollar amount of $250,000,000 as described in this prospectus. Each time that we offer and sell
securities, we will provide a prospectus supplement to this prospectus that contains specific information about the securities being offered and sold and the specific terms of that offering. We may also authorize one or more free writing
prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement or free writing prospectus may also add, update or change information contained in this prospectus with respect to that
offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or free writing prospectus, you should rely on the prospectus supplement or free writing prospectus, as applicable. Before
purchasing any securities, you should carefully read both this prospectus and the applicable prospectus supplement (and any applicable free writing prospectuses), together with the additional information described under the heading &#147;Where You
Can Find More Information; Incorporation by Reference.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not authorized anyone to provide you with any information or to make any
representations other than those contained in this prospectus, any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no
assurance as to the reliability of, any other information that others may give you. We will not make an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in
this prospectus and the applicable prospectus supplement to this prospectus is accurate only as of the date on its respective cover, that the information appearing in any applicable free writing prospectus is accurate only as of the date of that
free writing prospectus, and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, unless we indicate otherwise. Our business, financial condition, results of operations and
prospects may have changed since those dates. This prospectus incorporates by reference, and any prospectus supplement or free writing prospectus may contain and incorporate by reference, market data and industry statistics and forecasts that are
based on independent industry publications and other publicly available information. Although we believe these sources are reliable, we do not guarantee the accuracy or completeness of this information and we have not independently verified this
information. In addition, the market and industry data and forecasts that may be included or incorporated by reference in this prospectus, any prospectus supplement or any applicable free writing prospectus may involve estimates, assumptions and
other risks and uncertainties and are subject to change based on various factors, including those discussed under the heading &#147;Risk Factors&#148; contained in this prospectus, the applicable prospectus supplement and any applicable free writing
prospectus, and under similar headings in other documents that are incorporated by reference into this prospectus. Accordingly, investors should not place undue reliance on this information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When we refer to &#147;American Superconductor,&#148; &#147;we,&#148; &#147;our,&#148; &#147;us&#148; and the &#147;Company&#148; in this prospectus, we mean
American Superconductor Corporation and its consolidated subsidiaries, unless otherwise specified. When we refer to &#147;you,&#148; we mean the potential holders of the applicable series of securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">actiVAR, American Superconductor, Amperium, AMSC, armorVAR, <FONT STYLE="white-space:nowrap">D-VAR,</FONT> PowerModule,
<FONT STYLE="white-space:nowrap">D-VAR</FONT> VVO, <FONT STYLE="white-space:nowrap">PQ-IVR,</FONT> SeaTitan, Gridtec, Marinetec, Windtec, Smarter, Cleaner...Better Energy and Orchestrate the Rhythm and Harmony of Power on the Grid are our trademarks
or registered trademarks that are used in this prospectus and the documents incorporated by reference. This prospectus and the documents incorporated by reference also include trademarks, tradenames and service marks that are the property of other
organizations. Solely for convenience, trademarks and tradenames referred to in this prospectus and the documents incorporated by reference appear without the <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> and <SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP> symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not
assert its rights, to these trademarks and tradenames. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_14"></A>WHERE YOU CAN FIND MORE INFORMATION; INCORPORATION BY
REFERENCE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Available Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We file
reports, proxy statements and other information with the SEC. The SEC maintains a web site that contains reports, proxy and information statements and other information about issuers, such as us, who file electronically with the SEC. The address of
that website is <I>http://www.sec.gov</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our web site address is <I>www.amsc.com</I>. The information on our web site, however, is not, and should not
be deemed to be, a part of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus and any prospectus supplement are part of a registration statement that we filed with the SEC
and do not contain all of the information in the registration statement. The full registration statement may be obtained from the SEC or us, as provided below. Forms of the indenture and other documents establishing the terms of the offered
securities are or may be filed as exhibits to the registration statement or documents incorporated by reference in the registration statement. Statements in this prospectus or any prospectus supplement about these documents are summaries and each
statement is qualified in all respects by reference to the document to which it refers. You should refer to the actual documents for a more complete description of the relevant matters. You may inspect a copy of the registration statement through
the SEC&#146;s website, as provided above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Incorporation by Reference </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The SEC&#146;s rules allow us to &#147;incorporate by reference&#148; information into this prospectus, which means that we can disclose important information
to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and
supersede that information. Any statement contained in this prospectus or a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in
this prospectus or a subsequently filed document incorporated by reference modifies or replaces that statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus and any accompanying
prospectus supplement incorporate by reference the documents set forth below that have previously been filed with the SEC, excluding in each case any information furnished to, rather than filed with, the SEC: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774920012276/amsc20200331_10k.htm">
<FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT></A> for the fiscal year ended March&nbsp;31, 2021, filed with the SEC on June&nbsp;2, 2021. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Current Reports on <FONT STYLE="white-space:nowrap">Form&nbsp;
8-K</FONT> filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000119312521156251/d80808d8k.htm">May&nbsp;10, 2021</A>, <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000119312521168626/d73761d8k.htm">May&nbsp;
21, 2021</A> and <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774921013279/amsc20210525_8k.htm">May&nbsp;25, 2021</A> and Amended Current Report on Form&nbsp;
8-K/A filed with the SEC on <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774920025291/amsc20201120_8ka.htm">December&nbsp;14, 2020</A>. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The description of our Common Stock filed as <A HREF="http://www.sec.gov/Archives/edgar/data/880807/000143774919011477/ex_146280.htm">Exhibit
 4.3</A> in our Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended March&nbsp;31, 2019 filed with the SEC on June&nbsp;5, 2019, and any other amendment or report filed with the SEC for the purpose of updating the
description. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All reports and other documents we subsequently file pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Securities
Exchange Act of 1934, as amended, which we refer to as the &#147;Exchange Act&#148; in this prospectus, prior to the termination of this offering but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated
by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may request a
free copy of any of the documents incorporated by reference in this prospectus by writing or telephoning us at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">American Superconductor Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 East Main Street, Ayer, Massachusetts 01432 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Telephone: (978) <FONT STYLE="white-space:nowrap">842-3000</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Investor Relations </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Exhibits to the
filings will not be sent, however, unless those exhibits have specifically been incorporated by reference in this prospectus or any accompanying prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_15"></A>THE COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid<SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP>, and that protect and expand the capability of our Navy&#146;s fleet. Our solutions enhance the performance of the power grid, protect our Navy&#146;s fleet, and lower the cost of wind power. In
the power grid market, we enable electric utilities, industrial facilities, and renewable energy project developers to connect, transmit and distribute smarter, cleaner and better power through our transmission planning services and power
electronics and superconductor-based systems. In the wind power market, we enable manufacturers to field highly competitive wind turbines through our advanced power electronics and control system products, engineering, and support services. Our
power grid and wind products and services provide exceptional reliability, security, efficiency and affordability to our customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our power system
solutions help to improve energy efficiency, alleviate power grid capacity constraints, improve system resiliency, and increase the adoption of renewable energy generation. Demand for our solutions is driven by the growing needs for modernized smart
grids that improve power reliability, security and quality, the U.S. Navy&#146;s effort to upgrade <FONT STYLE="white-space:nowrap">in-board</FONT> power systems to support fleet electrification, and the need for increased renewable sources of
electricity, such as wind and solar energy. Concerns about these factors have led to increased spending by corporations and the military, as well as supportive government regulations and initiatives on local, state, and national levels, including
renewable portfolio standards, tax incentives and international treaties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We manufacture products using two proprietary core technologies: PowerModule<SUP
STYLE="font-size:75%; vertical-align:top">&#153;</SUP> programmable power electronic converters and our Amperium<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> high temperature superconductor (&#147;HTS&#148;) wires. These technologies
and our system-level solutions are protected by a broad and deep intellectual property portfolio consisting of hundreds of patents and licenses worldwide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We operate our business under two market-facing business units: Grid and Wind. We believe this market-centric structure enables us to more effectively
anticipate and meet the needs of power generation project developers, the Navy&#146;s ship protection systems, electric utilities and wind turbine manufacturers. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Grid</I>. Through our Gridtec<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> Solutions, our Grid
business segment enables electric utilities and renewable energy project developers to connect, transmit and distribute power with exceptional efficiency, reliability, security and affordability. We provide transmission planning services that allow
us to identify powe/r grid congestion, poor power quality, and other risks, which help us determine how our solutions can improve network performance. These services often lead to sales of our grid interconnection solutions for wind farms and solar
power plants, power quality systems and transmission and distribution cable systems. We also sell ship protection products to the U.S. Navy through our Grid business segment. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Wind</I>. Through our Windtec<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> Solutions, our Wind
business segment enables manufacturers to field wind turbines with exceptional power output, reliability and affordability. We supply advanced power electronics and control systems, license our highly engineered wind turbine designs, and provide
extensive customer support services to wind turbine manufacturers. Our design portfolio includes a broad range of drive trains and power ratings of 2 megawatts (&#147;MW&#148;) and higher. We provide a broad range of power electronics and
software-based control systems that are highly integrated and designed for optimized performance, efficiency, and grid compatibility. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were incorporated in the State of Delaware on April&nbsp;9, 1987. Our principal executive offices are located at 114 East Main Street, Ayer, Massachusetts
01432 and our telephone number is (978) <FONT STYLE="white-space:nowrap">842-3000.</FONT> Our website address is www.amsc.com. The information contained in, or accessible through, our website does not constitute a part of this prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_16"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investment in any securities offered pursuant to this prospectus and the applicable prospectus supplement involves risks. You should carefully consider the
risk factors incorporated by reference to our most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> our most recent Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and our recently filed Current
Reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> as well as any subsequent Annual Reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> or Current Reports on
Form <FONT STYLE="white-space:nowrap">8-K</FONT> we file after the date of this prospectus, and all other information contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange Act, and the
risk factors and other information contained in the applicable prospectus supplement and any applicable free writing prospectus before acquiring any of such securities. The occurrence of any of these risks might cause you to lose all or part of your
investment in the offered securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_17"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds from the sale of the securities as set forth in the applicable prospectus supplement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_18"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following description of our capital stock is intended as a summary only. This description is based upon, and is qualified by reference to, our restated
certificate of incorporation, as amended, our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> and applicable provisions of Delaware corporation law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our authorized capital stock consists of 75,000,000 shares of common stock, $0.01 par value per share. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annual Meeting</I>. Annual meetings of
our stockholders are held on the date designated in accordance with our amended and restated <FONT STYLE="white-space:nowrap">by-laws.</FONT> Written notice must be mailed to each stockholder entitled to vote not less than ten nor more than 60 days
before the date of the meeting. The presence in person or by proxy of the holders of a majority of our issued and outstanding shares entitled to vote at such meeting constitutes a quorum for the transaction of business at meetings of the
stockholders. Except as may be otherwise provided by applicable law, our restated certificate of incorporation or our amended and restated <FONT STYLE="white-space:nowrap">by-laws,</FONT> all elections shall be decided by a plurality of the votes
cast by stockholders entitled to vote in the election. All other matters shall be decided by a majority of the votes cast by stockholders entitled to vote thereon at a duly held meeting of stockholders at which a quorum is present. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Voting Rights</I>. Each holder of common stock is entitled to one vote for each share of stock held on all matters to be voted upon by stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Dividends</I>. The holders of common stock are entitled to receive dividends when and if declared by the board of directors out of legally available funds,
subject to any preferential dividend rights of holders of any preferred stock then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Liquidation and Dissolution</I>. If we are liquidated
or dissolved, the holders of the common stock will be entitled to share in our assets available for distribution to stockholders in proportion to the amount of common stock they own. The amount available for common stockholders is calculated after
payment of creditors and of any preferential liquidation rights of any preferred stock then outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Rights</I>. The holders of our common
stock have no right to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">convert the stock into any other security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">have the stock redeemed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchase additional stock; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintain their proportionate ownership interest. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The common stock does not have cumulative voting rights. Holders of shares of our common stock are not required to make additional capital contributions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Provisions of Our Amended and Restated <FONT STYLE="white-space:nowrap">By-laws</FONT> and Delaware Law That May Have Anti-Takeover Effects </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Special Meeting of Stockholders</I>. Our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> provide that special meetings of the
stockholders may be called for any purpose by our board of directors, the chairman of the board of directors or the president, but such special meetings may not be called by any other person or persons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Advance Notice Procedures</I>. Our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> contain advance notice procedures for stockholders
to make nominations of candidates for election as directors or to bring other business before the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
annual meeting of stockholders. Our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> provide that a stockholder must notify us in writing of any stockholder nomination of a
director or any business to be brought before an annual meeting by a stockholder not earlier than the 90th day and not later than the 120th day prior to the first anniversary of the preceding year&#146;s annual meeting; provided, that if the date of
the annual meeting is advanced by more than 20 days, or delayed by more than 60 days, from such anniversary date, notice by the stockholder to be timely must be so delivered not earlier than the 120th day prior to the date of such annual meeting and
not later than the later of (x)&nbsp;the 90th day prior to the date of such meeting and (y)&nbsp;the 10th day following the day on which notice of such special meeting was mailed or the day on which public disclosure of the date of such annual
meeting, whichever occurs first. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Forum Selection</I>. Our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> provide that, unless we
consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for: (a)&nbsp;any derivative action or proceeding brought on
behalf of us; (b)&nbsp;any action asserting a claim of breach of a fiduciary duty owed by any of our current or former director, officer, employee or stockholder to us or our stockholders; (c)&nbsp;any action asserting a claim against us arising
pursuant to any provision of the Delaware General Corporation Law or our restated certificate of incorporation or amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> or as to which the Delaware General Corporation Law confers
jurisdiction on the Court of Chancery of the State of Delaware; or (d)&nbsp;any action asserting a claim against us governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the
indispensable parties named as defendants therein; provided that, the exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Securities Act or the Exchange Act or any other claim for which the
federal courts have exclusive jurisdiction; and provided further that, if and only if the Court of Chancery of the State of Delaware dismisses any such action for lack of subject matter jurisdiction, such action may be brought in another state or
federal court sitting in the State of Delaware. Our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> also provide that the federal district courts of the United States of America will be the sole and exclusive forum for the
resolution of any complaint asserting a cause of action against us arising under the Securities Act. There is uncertainty as to whether a court would enforce such provisions, and the enforceability of similar choice of forum provisions in other
companies&#146; charter documents has been challenged in legal proceedings. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than
those designated in the exclusive forum provisions, and there can be no assurance that such provisions will be enforced by a court in those other jurisdictions. We note that investors cannot waive compliance with the federal securities laws and the
rules and regulations thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Delaware Business Combination Statute</I>. We are subject to Section&nbsp;203 of the General Corporation Law of the
State of Delaware. Section&nbsp;203 restricts some types of transactions and business combinations between a corporation and a 15% stockholder. A 15% stockholder is generally considered by Section&nbsp;203 to be a person owning 15% or more of the
corporation&#146;s outstanding voting stock. Section&nbsp;203 refers to a 15% stockholder as an &#147;interested stockholder.&#148; Section&nbsp;203 restricts these transactions for a period of three years from the date the stockholder acquires 15%
or more of our outstanding voting stock. With some exceptions, unless the transaction is approved by the board of directors and the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding voting stock of the
corporation, Section&nbsp;203 prohibits significant business transactions such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a merger with, disposition of significant assets to or receipt of disproportionate financial benefits by the
interested stockholder, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other transaction that would increase the interested stockholder&#146;s proportionate ownership of any class
or series of our capital stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares held by the interested stockholder are not counted as outstanding when calculating the <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding voting stock needed for approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The prohibition against these transactions does not apply if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to the time that any stockholder became an interested stockholder, the board of directors approved either
the business combination or the transaction in which such stockholder acquired 15% or more of our outstanding voting stock, or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the interested stockholder owns at least 85% of our outstanding voting stock as a result of a transaction in
which such stockholder acquired 15% or more of our outstanding voting stock. Shares held by persons who are both directors and officers or by some types of employee stock plans are not counted as outstanding when making this calculation.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_19"></A>DESCRIPTION OF DEBT SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following description, together with the additional information we include in any applicable prospectus supplement or free writing prospectus, summarizes
certain general terms and provisions of the debt securities that we may offer under this prospectus. When we offer to sell a particular series of debt securities, we will describe the specific terms of the series in a supplement to this prospectus.
We will also indicate in the supplement to what extent the general terms and provisions described in this prospectus apply to a particular series of debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue debt securities either separately, or together with, or upon the conversion or exercise of or in exchange for, other securities described in this
prospectus. Debt securities may be our senior, senior subordinated or subordinated obligations and, unless otherwise specified in a supplement to this prospectus, the debt securities will be our direct, unsecured obligations and may be issued in one
or more series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The debt securities will be issued under an indenture between us and a trustee to be named in the applicable indenture. We have
summarized select portions of the indenture below. The summary is not complete. The form of the indenture has been filed as an exhibit to the registration statement and you should read the indenture for provisions that may be important to you. In
the summary below, we have included references to the section numbers of the indenture so that you can easily locate these provisions. Capitalized terms used in the summary and not defined herein have the meanings specified in the indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in this section only, &#147;American Superconductor,&#148; &#147;we,&#148; &#147;our&#148; or &#147;us&#148; refer to American Superconductor
Corporation, excluding our subsidiaries, unless expressly stated or the context otherwise requires. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms of each series of debt securities will be established by or pursuant to a resolution of our board of directors and set forth or determined in the
manner provided in a resolution of our board of directors, in an officer&#146;s certificate or by a supplemental indenture. (Section 2.2) The particular terms of each series of debt securities will be described in a prospectus supplement relating to
such series (including any pricing supplement or term sheet). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We can issue an unlimited amount of debt securities under the indenture that may be in one
or more series with the same or various maturities, at par, at a premium, or at a discount. (Section 2.1) We will set forth in a prospectus supplement (including any pricing supplement or term sheet) relating to any series of debt securities being
offered, the aggregate principal amount and the following terms of the debt securities, if applicable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the title and ranking of the debt securities (including the terms of any subordination provisions);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price or prices (expressed as a percentage of the principal amount) at which we will sell the debt
securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any limit on the aggregate principal amount of the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date or dates on which the principal of the securities of the series is payable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate or rates (which may be fixed or variable) per annum or the method used to determine the rate or rates
(including any commodity, commodity index, stock exchange index or financial index) at which the debt securities will bear interest, the date or dates from which interest will accrue, the date or dates on which interest will commence and be payable
and any regular record date for the interest payable on any interest payment date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the place or places where principal of, and interest, if any, on the debt securities will be payable (and the
method of such payment), where the securities of such series may be surrendered for registration of transfer or exchange, and where notices and demands to us in respect of the debt securities may be delivered; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the period or periods within which, the price or prices at which and the terms and conditions upon which we may
redeem the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or analogous
provisions or at the option of a holder of debt securities and the period or periods within which, the price or prices at which and in the terms and conditions upon which securities of the series shall be redeemed or purchased, in whole or in part,
pursuant to such obligation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the dates on which and the price or prices at which we will repurchase debt securities at the option of the
holders of debt securities and other detailed terms and provisions of these repurchase obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any
integral multiple thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the debt securities will be issued in the form of certificated debt securities or global debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity
date, if other than the principal amount; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the currency of denomination of the debt securities, which may be United States Dollars or any foreign currency,
and if such currency of denomination is a composite currency, the agency or organization, if any, responsible for overseeing such composite currency; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the designation of the currency, currencies or currency units in which payment of principal of, premium and
interest on the debt securities will be made; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if payments of principal of, premium or interest on the debt securities will be made in one or more currencies or
currency units other than that or those in which the debt securities are denominated, the manner in which the exchange rate with respect to these payments will be determined; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the manner in which the amounts of payment of principal of, premium, if any, or interest on the debt securities
will be determined, if these amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any provisions relating to any security provided for the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any addition to, deletion of or change in the Events of Default described in this prospectus or in the indenture
with respect to the debt securities and any change in the acceleration provisions described in this prospectus or in the indenture with respect to the debt securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any addition to, deletion of or change in the covenants described in this prospectus or in the indenture with
respect to the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect
to the debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the provisions, if any, relating to conversion or exchange of any debt securities of such series, including if
applicable, the conversion or exchange price and period, provisions as to whether conversion or exchange will be mandatory, the events requiring an adjustment of the conversion or exchange price and provisions affecting conversion or exchange;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other terms of the debt securities, which may supplement, modify or delete any provision of the indenture as
it applies to that series, including any terms that may be required under applicable law or regulations or advisable in connection with the marketing of the securities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether any of our direct or indirect subsidiaries will guarantee the debt securities of that series, including
the terms of subordination, if any, of such guarantees. (Section 2.2) </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may issue debt securities that provide for an amount less than their stated principal amount to be due
and payable upon declaration of acceleration of their maturity pursuant to the terms of the indenture. We will provide you with information on the federal income tax considerations and other special considerations applicable to any of these debt
securities in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we denominate the purchase price of any of the debt securities in a foreign currency or currencies
or a foreign currency unit or units, or if the principal of and any premium and interest on any series of debt securities is payable in a foreign currency or currencies or a foreign currency unit or units, we will provide you with information on the
restrictions, elections, general tax considerations, specific terms and other information with respect to that issue of debt securities and such foreign currency or currencies or foreign currency unit or units in the applicable prospectus
supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer and Exchange </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each debt
security will be represented by either one or more global securities registered in the name of The Depository Trust Company, or the Depositary, or a nominee of the Depositary (we will refer to any debt security represented by a global debt security
as a &#147;book-entry debt security&#148;), or a certificate issued in definitive registered form (we will refer to any debt security represented by a certificated security as a &#147;certificated debt security&#148;) as set forth in the applicable
prospectus supplement. Except as set forth under the heading &#147;Global Debt Securities and Book-Entry System&#148; below, book-entry debt securities will not be issuable in certificated form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certificated Debt Securities</I>. You may transfer or exchange certificated debt securities at any office we maintain for this purpose in accordance with
the terms of the indenture. (Section 2.4) No service charge will be made for any transfer or exchange of certificated debt securities, but we may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection
with a transfer or exchange. (Section 2.7) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may effect the transfer of certificated debt securities and the right to receive the principal of, premium
and interest on certificated debt securities only by surrendering the certificate representing those certificated debt securities and either reissuance by us or the trustee of the certificate to the new holder or the issuance by us or the trustee of
a new certificate to the new holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Global Debt Securities and Book-Entry System</I>. Each global debt security representing book-entry debt
securities will be deposited with, or on behalf of, the Depositary, and registered in the name of the Depositary or a nominee of the Depositary. Please see &#147;Global Securities.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Covenants </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will set forth in the applicable prospectus
supplement any restrictive covenants applicable to any issue of debt securities. (Article IV) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Protection in the Event of a Change of Control
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless we state otherwise in the applicable prospectus supplement, the debt securities will not contain any provisions which may afford holders of the
debt securities protection in the event we have a change in control or in the event of a highly leveraged transaction (whether or not such transaction results in a change in control) which could adversely affect holders of debt securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consolidation, Merger and Sale of Assets </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may not
consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our properties and assets to any person (a &#147;successor person&#148;) unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we are the surviving corporation or the successor person (if other than American Superconductor) is a corporation
organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly assumes our obligations on the debt securities and under the indenture; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">immediately after giving effect to the transaction, no Default or Event of Default, shall have occurred and be
continuing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the above, any of our subsidiaries may consolidate with, merge into or transfer all or part of its
properties to us. (Section 5.1) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Events of Default </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Event of Default&#148; means with respect to any series of debt securities, any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in the payment of any interest upon any debt security of that series when it becomes due and payable, and
continuance of such default for a period of 30 days (unless the entire amount of the payment is deposited by us with the trustee or with a paying agent prior to the expiration of the <FONT STYLE="white-space:nowrap">30-day</FONT> period);
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in the payment of principal of any security of that series at its maturity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">default in the performance or breach of any other covenant or warranty by us in the indenture (other than a
covenant or warranty that has been included in the indenture solely for the benefit of a series of debt securities other than that series), which default continues uncured for a period of 60 days after we receive written notice from the trustee or
American Superconductor and the trustee receive written notice from the holders of not less than 25% in principal amount of the outstanding debt securities of that series as provided in the indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain voluntary or involuntary events of bankruptcy, insolvency or reorganization of American Superconductor;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any other Event of Default provided with respect to debt securities of that series that is described in the
applicable prospectus supplement. (Section 6.1) </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No Event of Default with respect to a particular series of debt securities (except as
to certain events of bankruptcy, insolvency or reorganization) necessarily constitutes an Event of Default with respect to any other series of debt securities. (Section 6.1) The occurrence of certain Events of Default or an acceleration under the
indenture may constitute an event of default under certain indebtedness of ours or our subsidiaries outstanding from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will provide the
trustee written notice of any Default or Event of Default within 30 days of becoming aware of the occurrence of such Default or Event of Default, which notice will describe in reasonable detail the status of such Default or Event of Default and what
action we are taking or propose to take in respect thereof. (Section&nbsp;6.1) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an Event of Default with respect to debt securities of any series at
the time outstanding occurs and is continuing, then the trustee or the holders of not less than 25% in principal amount of the outstanding debt securities of that series may, by a notice in writing to us (and to the trustee if given by the holders),
declare to be due and payable immediately the principal of (or, if the debt securities of that series are discount securities, that portion of the principal amount as may be specified in the terms of that series) and accrued and unpaid interest, if
any, on all debt securities of that series. In the case of an Event of Default resulting from certain events of bankruptcy, insolvency or reorganization, the principal (or such specified amount) of and accrued and unpaid interest, if any, on all
outstanding debt securities will become and be immediately due and payable without any declaration or other act on the part of the trustee or any holder of outstanding debt securities. At any time after a declaration of acceleration with respect to
debt securities of any series has been made, but before a judgment or decree for payment of the money due has been obtained by the trustee, the holders of a majority in principal amount of the outstanding debt securities of that series may rescind
and annul the acceleration if all Events of Default, other than the <FONT STYLE="white-space:nowrap">non-payment</FONT> of accelerated principal and interest, if any, with respect to debt securities of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that series, have been cured or waived as provided in the indenture. (Section 6.2) We refer you to the prospectus supplement relating to any series of debt securities that are discount securities
for the particular provisions relating to acceleration of a portion of the principal amount of such discount securities upon the occurrence of an Event of Default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture provides that the trustee may refuse to perform any duty or exercise any of its rights or powers under the indenture unless the trustee receives
indemnity satisfactory to it against any cost, liability or expense which might be incurred by it in performing such duty or exercising such right or power. (Section 7.1(e)) Subject to certain rights of the trustee, the holders of a majority in
principal amount of the outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the trustee or exercising any trust or power conferred on the trustee
with respect to the debt securities of that series. (Section 6.12) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No holder of any debt security of any series will have any right to institute any
proceeding, judicial or otherwise, with respect to the indenture or for the appointment of a receiver or trustee, or for any remedy under the indenture, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">that holder has previously given to the trustee written notice of a continuing Event of Default with respect to
debt securities of that series; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the holders of not less than 25% in principal amount of the outstanding debt securities of that series have made
written request, and offered indemnity or security satisfactory to the trustee, to the trustee to institute the proceeding as trustee, and the trustee has not received from the holders of not less than a majority in principal amount of the
outstanding debt securities of that series a direction inconsistent with that request and has failed to institute the proceeding within 60 days. (Section 6.7) </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provision in the indenture, the holder of any debt security will have an absolute and unconditional right to receive payment of the
principal of, premium and any interest on that debt security on or after the due dates expressed in that debt security and to institute suit for the enforcement of payment. (Section&nbsp;6.8) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture requires us, within 120 days after the end of our fiscal year, to furnish to the trustee a statement as to compliance with the indenture.
(Section 4.3) If a Default or Event of Default occurs and is continuing with respect to the securities of any series and if it is known to a responsible officer of the trustee, the trustee shall mail to each holder of the debt securities of that
series notice of a Default or Event of Default within 90 days after it occurs or, if later, after a responsible officer of the trustee has knowledge of such Default or Event of Default. The indenture provides that the trustee may withhold notice to
the holders of debt securities of any series of any Default or Event of Default (except in payment on any debt securities of that series) with respect to debt securities of that series if the trustee determines in good faith that withholding notice
is in the interest of the holders of those debt securities. (Section 7.5) </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Modification and Waiver </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We and the trustee may modify, amend or supplement the indenture or the debt securities of any series without the consent of any holder of any debt security:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to cure any ambiguity, defect or inconsistency; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to comply with covenants in the indenture described above under the heading &#147;Consolidation, Merger and Sale
of Assets&#148;; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to provide for uncertificated securities in addition to or in place of certificated securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add guarantees with respect to debt securities of any series or secure debt securities of any series;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to surrender any of our rights or powers under the indenture; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to add covenants or events of default for the benefit of the holders of debt securities of any series;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to comply with the applicable procedures of the applicable depositary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to make any change that does not adversely affect the rights of any holder of debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to provide for the issuance of and establish the form and terms and conditions of debt securities of any series
as permitted by the indenture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to effect the appointment of a successor trustee with respect to the debt securities of any series and to add to
or change any of the provisions of the indenture to provide for or facilitate administration by more than one trustee; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to comply with requirements of the SEC in order to effect or maintain the qualification of the indenture under
the Trust Indenture Act. (Section 9.1) </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may also modify and amend the indenture with the consent of the holders of at least a
majority in principal amount of the outstanding debt securities of each series affected by the modifications or amendments. We may not make any modification or amendment without the consent of the holders of each affected debt security then
outstanding if that amendment will: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the amount of debt securities whose holders must consent to an amendment, supplement or waiver;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the rate of or extend the time for payment of interest (including default interest) on any debt security;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the principal of or premium on or change the fixed maturity of any debt security or reduce the amount of,
or postpone the date fixed for, the payment of any sinking fund or analogous obligation with respect to any series of debt securities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduce the principal amount of discount securities payable upon acceleration of maturity; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">waive a default in the payment of the principal of, premium or interest on any debt security (except a rescission
of acceleration of the debt securities of any series by the holders of at least a majority in aggregate principal amount of the then outstanding debt securities of that series and a waiver of the payment default that resulted from such
acceleration); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make the principal of or premium or interest on any debt security payable in currency other than that stated in
the debt security; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make any change to certain provisions of the indenture relating to, among other things, the right of holders of
debt securities to receive payment of the principal of, premium and interest on those debt securities and to institute suit for the enforcement of any such payment and to waivers or amendments; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">waive a redemption payment with respect to any debt security. (Section 9.3) </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except for certain specified provisions, the holders of at least a majority in principal amount of the outstanding debt securities of any series may on behalf
of the holders of all debt securities of that series waive our compliance with provisions of the indenture. (Section 9.2) The holders of a majority in principal amount of the outstanding debt securities of any series may on behalf of the holders of
all the debt securities of such series waive any past default under the indenture with respect to that series and its consequences, except a default in the payment of the principal of, premium or any interest on any debt security of that series;
provided, however, that the holders of a majority in principal amount of the outstanding debt securities of any series may rescind an acceleration and its consequences, including any related payment default that resulted from the acceleration.
(Section 6.13) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Defeasance of Debt Securities and Certain Covenants in Certain Circumstances </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Legal Defeasance</I>. The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, we may be discharged
from any and all obligations in respect of the debt securities of any series (subject to certain exceptions). We will be so discharged upon the irrevocable deposit with the trustee, in trust, of money and/or U.S. government obligations or, in the
case of debt securities denominated in a single currency other than U.S. Dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their
terms, will provide money or U.S. government obligations in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment of principal, premium and
interest on and any mandatory sinking fund payments in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discharge may occur only if, among other things, we have delivered to the trustee an opinion of counsel stating that we have received from, or there has
been published by, the United States Internal Revenue Service a ruling or, since the date of execution of the indenture, there has been a change in the applicable United States federal income tax law, in either case to the effect that, and based
thereon such opinion shall confirm that, the holders of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit, defeasance and discharge and will be subject
to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit, defeasance and discharge had not occurred. (Section 8.3) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Defeasance of Certain Covenants</I>. The indenture provides that, unless otherwise provided by the terms of the applicable series of debt securities, upon
compliance with certain conditions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may omit to comply with the covenant described under the heading &#147;Consolidation, Merger and Sale of
Assets&#148; and certain other covenants set forth in the indenture, as well as any additional covenants which may be set forth in the applicable prospectus supplement; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any omission to comply with those covenants will not constitute a Default or an Event of Default with respect to
the debt securities of that series (&#147;covenant defeasance&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The conditions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">depositing with the trustee money and/or U.S. government obligations or, in the case of debt securities
denominated in a single currency other than U.S. Dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their terms, will provide
money in an amount sufficient in the opinion of a nationally recognized firm of independent public accountants or investment bank to pay and discharge each installment of principal of, premium and interest on and any mandatory sinking fund payments
in respect of the debt securities of that series on the stated maturity of those payments in accordance with the terms of the indenture and those debt securities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivering to the trustee an opinion of counsel to the effect that the holders of the debt securities of that
series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit and related covenant defeasance and will be subject to United States federal income tax on the same amounts and in the same
manner and at the same times as would have been the case if the deposit and related covenant defeasance had not occurred. (Section 8.4) </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Personal Liability of Directors, Officers, Employees or Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of our past, present or future directors, officers, employees or stockholders, as such, will have any liability for any of our obligations under the debt
securities or the indenture or for any claim based on, or in respect or by reason of, such obligations or their creation. By accepting a debt security, each holder waives and releases all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such liability. This waiver and release is part of the consideration for the issue of the debt securities. (Section&nbsp;10.8) However, this waiver and release may not be effective to waive
liabilities under U.S. federal securities laws, and it is the view of the SEC that such a waiver is against public policy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Governing Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture and the debt securities, including any claim or controversy arising out of or relating to the indenture or the securities, will be governed by
the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture will provide that we, the trustee and the holders of the debt securities (by their acceptance of the
debt securities) irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to the indenture, the debt securities or the transactions contemplated
thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The indenture will provide that any legal suit, action or proceeding arising out of or based upon the indenture or the transactions contemplated
thereby may be instituted in the federal courts of the United States of America located in the City of New York or the courts of the State of New York in each case located in the City of New York, and we, the trustee and the holder of the debt
securities (by their acceptance of the debt securities) irrevocably submit to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of such courts in any such suit, action or proceeding. The indenture will further provide that
service of any process, summons, notice or document by mail (to the extent allowed under any applicable statute or rule of court) to such party&#146;s address set forth in the indenture will be effective service of process for any suit, action or
other proceeding brought in any such court. The indenture will further provide that we, the trustee and the holders of the debt securities (by their acceptance of the debt securities) irrevocably and unconditionally waive any objection to the laying
of venue of any suit, action or other proceeding in the courts specified above and irrevocably and unconditionally waive and agree not to plead or claim any such suit, action or other proceeding has been brought in an inconvenient forum. (Section
10.10) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_20"></A>DESCRIPTION OF OTHER SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will set forth in the applicable prospectus supplement a description of any warrants or units issued by us that may be offered and sold pursuant to this
prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_21"></A>GLOBAL SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Book-Entry, Delivery and Form </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless we indicate
differently in any applicable prospectus supplement or free writing prospectus, the securities initially will be issued in book-entry form and represented by one or more global notes or global securities, or, collectively, global securities. The
global securities will be deposited with, or on behalf of, The Depository Trust Company, New York, New York, as depositary, or DTC, and registered in the name of Cede&nbsp;&amp; Co., the nominee of DTC. Unless and until it is exchanged for
individual certificates evidencing securities under the limited circumstances described below, a global security may not be transferred except as a whole by the depositary to its nominee or by the nominee to the depositary, or by the depositary or
its nominee to a successor depositary or to a nominee of the successor depositary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC has advised us that it is: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a limited-purpose trust company organized under the New York Banking Law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;banking organization&#148; within the meaning of the New York Banking Law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a member of the Federal Reserve System; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;clearing corporation&#148; within the meaning of the New York Uniform Commercial Code; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a &#147;clearing agency&#148; registered pursuant to the provisions of Section&nbsp;17A of the Exchange Act.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC holds securities that its participants deposit with DTC. DTC also facilitates the settlement among its participants of securities
transactions, such as transfers and pledges, in deposited securities through electronic computerized book-entry changes in participants&#146; accounts, thereby eliminating the need for physical movement of securities certificates. &#147;Direct
participants&#148; in DTC include securities brokers and dealers, including underwriters, banks, trust companies, clearing corporations and other organizations. DTC is a wholly-owned subsidiary of The Depository Trust&nbsp;&amp; Clearing
Corporation, or DTCC. DTCC is the holding company for DTC, National Securities Clearing Corporation and Fixed Income Clearing Corporation, all of which are registered clearing agencies. DTCC is owned by the users of its regulated subsidiaries.
Access to the DTC system is also available to others, which we sometimes refer to as indirect participants, that clear through or maintain a custodial relationship with a direct participant, either directly or indirectly. The rules applicable to DTC
and its participants are on file with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Purchases of securities under the DTC system must be made by or through direct participants, which will
receive a credit for the securities on DTC&#146;s records. The ownership interest of the actual purchaser of a security, which we sometimes refer to as a beneficial owner, is in turn recorded on the direct and indirect participants&#146; records.
Beneficial owners of securities will not receive written confirmation from DTC of their purchases. However, beneficial owners are expected to receive written confirmations providing details of their transactions, as well as periodic statements of
their holdings, from the direct or indirect participants through which they purchased securities. Transfers of ownership interests in global securities are to be accomplished by entries made on the books of participants acting on behalf of
beneficial owners. Beneficial owners will not receive certificates representing their ownership interests in the global securities, except under the limited circumstances described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To facilitate subsequent transfers, all global securities deposited by direct participants with DTC will be registered in the name of DTC&#146;s partnership
nominee, Cede&nbsp;&amp; Co., or such other name as may be requested by an authorized representative of DTC. The deposit of securities with DTC and their registration in the name of Cede&nbsp;&amp; Co. or such other nominee will not change the
beneficial ownership of the securities. DTC has no knowledge of the actual beneficial owners of the securities. DTC&#146;s records reflect only the identity of the direct participants to whose accounts the securities are credited, which may or may
not be the beneficial owners. The participants are responsible for keeping account of their holdings on behalf of their customers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">So long as the securities are in book-entry form, you will receive payments and may transfer securities only
through the facilities of the depositary and its direct and indirect participants. We will maintain an office or agency in the location specified in the prospectus supplement for the applicable securities, where notices and demands in respect of the
securities and the indenture may be delivered to us and where certificated securities may be surrendered for payment, registration of transfer or exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Conveyance of notices and other communications by DTC to direct participants, by direct participants to indirect participants and by direct participants and
indirect participants to beneficial owners will be governed by arrangements among them, subject to any legal requirements in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redemption notices will be sent to DTC. If less than all of the securities of a particular series are being redeemed, DTC&#146;s practice is to determine by
lot the amount of the interest of each direct participant in the securities of such series to be redeemed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither DTC nor Cede&nbsp;&amp; Co. (or such
other DTC nominee) will consent or vote with respect to the securities. Under its usual procedures, DTC will mail an omnibus proxy to us as soon as possible after the record date. The omnibus proxy assigns the consenting or voting rights of
Cede&nbsp;&amp; Co. to those direct participants to whose accounts the securities of such series are credited on the record date, identified in a listing attached to the omnibus proxy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">So long as securities are in book-entry form, we will make payments on those securities to the depositary or its nominee, as the registered owner of such
securities, by wire transfer of immediately available funds. If securities are issued in definitive certificated form under the limited circumstances described below and unless if otherwise provided in the description of the applicable securities
herein or in the applicable prospectus supplement, we will have the option of making payments by check mailed to the addresses of the persons entitled to payment or by wire transfer to bank accounts in the United States designated in writing to the
applicable trustee or other designated party at least 15 days before the applicable payment date by the persons entitled to payment, unless a shorter period is satisfactory to the applicable trustee or other designated party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redemption proceeds, distributions and dividend payments on the securities will be made to Cede&nbsp;&amp; Co., or such other nominee as may be requested by
an authorized representative of DTC. DTC&#146;s practice is to credit direct participants&#146; accounts upon DTC&#146;s receipt of funds and corresponding detail information from us on the payment date in accordance with their respective holdings
shown on DTC records. Payments by participants to beneficial owners will be governed by standing instructions and customary practices, as is the case with securities held for the account of customers in bearer form or registered in &#147;street
name.&#148; Those payments will be the responsibility of participants and not of DTC or us, subject to any statutory or regulatory requirements in effect from time to time. Payment of redemption proceeds, distributions and dividend payments to
Cede&nbsp;&amp; Co., or such other nominee as may be requested by an authorized representative of DTC, is our responsibility, disbursement of payments to direct participants is the responsibility of DTC, and disbursement of payments to the
beneficial owners is the responsibility of direct and indirect participants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except under the limited circumstances described below, purchasers of
securities will not be entitled to have securities registered in their names and will not receive physical delivery of securities. Accordingly, each beneficial owner must rely on the procedures of DTC and its participants to exercise any rights
under the securities and the indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The laws of some jurisdictions may require that some purchasers of securities take physical delivery of
securities in definitive form. Those laws may impair the ability to transfer or pledge beneficial interests in securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DTC may discontinue providing
its services as securities depositary with respect to the securities at any time by giving reasonable notice to us. Under such circumstances, in the event that a successor depositary is not obtained, securities certificates are required to be
printed and delivered. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As noted above, beneficial owners of a particular series of securities generally will not receive
certificates representing their ownership interests in those securities. However, if: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">DTC notifies us that it is unwilling or unable to continue as a depositary for the global security or securities
representing such series of securities or if DTC ceases to be a clearing agency registered under the Exchange Act at a time when it is required to be registered and a successor depositary is not appointed within 90 days of the notification to us or
of our becoming aware of DTC&#146;s ceasing to be so registered, as the case may be; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we determine, in our sole discretion, not to have such securities represented by one or more global securities;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an Event of Default has occurred and is continuing with respect to such series of securities,
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">we will prepare and deliver certificates for such securities in exchange for beneficial interests in the global securities. Any
beneficial interest in a global security that is exchangeable under the circumstances described in the preceding sentence will be exchangeable for securities in definitive certificated form registered in the names that the depositary directs. It is
expected that these directions will be based upon directions received by the depositary from its participants with respect to ownership of beneficial interests in the global securities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Euroclear and Clearstream </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If so provided in the
applicable prospectus supplement, you may hold interests in a global security through Clearstream Banking S.A., which we refer to as &#147;Clearstream,&#148; or Euroclear Bank S.A./N.V., as operator of the Euroclear System, which we refer to as
&#147;Euroclear,&#148; either directly if you are a participant in Clearstream or Euroclear or indirectly through organizations which are participants in Clearstream or Euroclear. Clearstream and Euroclear will hold interests on behalf of their
respective participants through customers&#146; securities accounts in the names of Clearstream and Euroclear, respectively, on the books of their respective U.S. depositaries, which in turn will hold such interests in customers&#146; securities
accounts in such depositaries&#146; names on DTC&#146;s books. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clearstream and Euroclear are securities clearance systems in Europe. Clearstream and
Euroclear hold securities for their respective participating organizations and facilitate the clearance and settlement of securities transactions between those participants through electronic book-entry changes in their accounts, thereby eliminating
the need for physical movement of certificates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payments, deliveries, transfers, exchanges, notices and other matters relating to beneficial interests in
global securities owned through Euroclear or Clearstream must comply with the rules and procedures of those systems. Transactions between participants in Euroclear or Clearstream, on one hand, and other participants in DTC, on the other hand, are
also subject to DTC&#146;s rules and procedures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investors will be able to make and receive through Euroclear and Clearstream payments, deliveries,
transfers and other transactions involving any beneficial interests in global securities held through those systems only on days when those systems are open for business. Those systems may not be open for business on days when banks, brokers and
other institutions are open for business in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cross-market transfers between participants in DTC, on the one hand, and participants in
Euroclear or Clearstream, on the other hand, will be effected through DTC in accordance with the DTC&#146;s rules on behalf of Euroclear or Clearstream, as the case may be, by their respective U.S. depositaries; however, such cross-market
transactions will require delivery of instructions to Euroclear or Clearstream, as the case may be, by the counterparty in such system in accordance with the rules and procedures and within the established deadlines (European time) of such system.
Euroclear or Clearstream, as the case may be, will, if the transaction meets its settlement requirements, deliver instructions to its U.S. depositary to take action to effect final settlement on its behalf by delivering or receiving interests in the
global securities through DTC, and making or receiving </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
payment in accordance with normal procedures for <FONT STYLE="white-space:nowrap">same-day</FONT> fund settlement. Participants in Euroclear or Clearstream may not deliver instructions directly
to their respective U.S. depositaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to time zone differences, the securities accounts of a participant in Euroclear or Clearstream purchasing an
interest in a global security from a direct participant in DTC will be credited, and any such crediting will be reported to the relevant participant in Euroclear or Clearstream, during the securities settlement processing day (which must be a
business day for Euroclear or Clearstream) immediately following the settlement date of DTC. Cash received in Euroclear or Clearstream as a result of sales of interests in a global security by or through a participant in Euroclear or Clearstream to
a direct participant in DTC will be received with value on the settlement date of DTC but will be available in the relevant Euroclear or Clearstream cash account only as of the business day for Euroclear or Clearstream following DTC&#146;s
settlement date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information in
this section of this prospectus concerning DTC, Clearstream, Euroclear and their respective book-entry systems has been obtained from sources that we believe to be reliable, but we do not take responsibility for this information. This information
has been provided solely as a matter of convenience. The rules and procedures of DTC, Clearstream and Euroclear are solely within the control of those organizations and could change at any time. Neither we nor the trustee nor any agent of ours or of
the trustee has any control over those entities and none of us takes any responsibility for their activities. You are urged to contact DTC, Clearstream and Euroclear or their respective participants directly to discuss those matters. In addition,
although we expect that DTC, Clearstream and Euroclear will perform the foregoing procedures, none of them is under any obligation to perform or continue to perform such procedures and such procedures may be discontinued at any time. Neither we nor
any agent of ours will have any responsibility for the performance or nonperformance by DTC, Clearstream and Euroclear or their respective participants of these or any other rules or procedures governing their respective operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_22"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may sell the securities from time to time pursuant to underwritten public offerings, negotiated transactions, block trades or a combination of these
methods or through underwriters or dealers, through agents and/or directly to one or more purchasers. The securities may be distributed from time to time in one or more transactions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a fixed price or prices, which may be changed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at market prices prevailing at the time of sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at prices related to such prevailing market prices; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at negotiated prices. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each time that we sell securities covered by this prospectus, we will provide a prospectus supplement or supplements that will describe the method of
distribution and set forth the terms and conditions of the offering of such securities, including the offering price of the securities and the proceeds to us, if applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Offers to purchase the securities being offered by this prospectus may be solicited directly. Agents may also be designated to solicit offers to purchase the
securities from time to time. Any agent involved in the offer or sale of our securities will be identified in a prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a dealer is
utilized in the sale of the securities being offered by this prospectus, the securities will be sold to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of
resale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an underwriter is utilized in the sale of the securities being offered by this prospectus, an underwriting agreement will be executed with the
underwriter at the time of sale and the name of any underwriter will be provided in the prospectus supplement that the underwriter will use to make resales of the securities to the public. In connection with the sale of the securities, we or the
purchasers of securities for whom the underwriter may act as agent, may compensate the underwriter in the form of underwriting discounts or commissions. The underwriter may sell the securities to or through dealers, and those dealers may receive
compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers for which they may act as agent. Unless otherwise indicated in a prospectus supplement, an agent will be acting on a best
efforts basis and a dealer will purchase securities as a principal, and may then resell the securities at varying prices to be determined by the dealer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any compensation paid to underwriters, dealers or agents in connection with the offering of the securities, and any discounts, concessions or commissions
allowed by underwriters to participating dealers will be provided in the applicable prospectus supplement. Underwriters, dealers and agents participating in the distribution of the securities may be deemed to be underwriters within the meaning of
the Securities Act of 1933, as amended, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions. We may enter into agreements to
indemnify underwriters, dealers and agents against civil liabilities, including liabilities under the Securities Act, or to contribute to payments they may be required to make in respect thereof and to reimburse those persons for certain expenses.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any common stock will be listed on the Nasdaq Global Select Market, but any other securities may or may not be listed on a national securities exchange.
To facilitate the offering of securities, certain persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of the securities. This may include over-allotments or short sales of the
securities, which involve the sale by persons participating in the offering of more securities than were sold to them. In these circumstances, these persons would cover such over-allotments or short positions by making purchases in the open market
or by exercising their over-allotment option, if any. In addition, these persons may stabilize or maintain the price of the securities by bidding for or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to dealers participating in the offering may be reclaimed if securities sold by them are
repurchased in connection with stabilization transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market. These transactions
may be discontinued at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may engage in at the market offerings into an existing trading market in accordance with Rule 415(a)(4) under the
Securities Act. In addition, we may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement so indicates,
in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us or
borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third party in
such sale transactions will be an underwriter and, if not identified in this prospectus, will be named in the applicable prospectus supplement (or a post-effective amendment). In addition, we may otherwise loan or pledge securities to a financial
institution or other third party that in turn may sell the securities short using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer its economic short position to investors in our
securities or in connection with a concurrent offering of other securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The specific terms of any <FONT STYLE="white-space:nowrap">lock-up</FONT>
provisions in respect of any given offering will be described in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters, dealers and agents may engage in
transactions with us, or perform services for us, in the ordinary course of business for which they receive compensation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_23"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins LLP will pass upon certain legal matters relating to the issuance and sale of the securities offered hereby on behalf of American
Superconductor Corporation. Additional legal matters may be passed upon for us or any underwriters, dealers or agents, by counsel that we will name in the applicable prospectus supplement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="supprom719447_24"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of American Superconductor Corporation as of March&nbsp;31, 2021 and 2020 and for the years then ended incorporated in
this Prospectus by reference from the American Superconductor Corporation Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended March&nbsp;31, 2021 have been audited by RSM US LLP, an independent registered public
accounting firm, as stated in their report thereon, incorporated herein by reference, and have been incorporated in this Prospectus and Registration Statement in reliance upon such report and upon the authority of such firm as experts in accounting
and auditing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The consolidated balance sheet of Northeast Power Systems, Inc. as of December&nbsp;31, 2019, the consolidated statements of income,
stockholders&#146; and members&#146; equity, and cash flows for the year ended December&nbsp;31, 2019 incorporated by reference to American Superconductor Corporation&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K/A</FONT> filed
with the SEC on December&nbsp;14, 2020, have been audited by Teal, Becker&nbsp;&amp; Chiaramonte, CPA&#146;S, P.C. as stated in their report dated December&nbsp;8, 2020 incorporated by reference herein, and have been so incorporated in reliance upon
such report and upon the authority of such firm as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:80pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>5,400,000 Shares </B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g719447g79p77.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:80pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:39%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROSPECTUS
SUPPLEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:39%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Sole Book-Running Manager </I></B></P>
<P STYLE="margin-top:80pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Oppenheimer&nbsp;&amp; Co. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I></I></B><I>Co-Managers</I><B><I> </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Craig-Hallum</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Roth Capital Partners</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>January 30, 2024 </B></P> <P STYLE="font-size:80pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g719447g79p77.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g719447g79p77.jpg
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M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
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M.'2RCEPJ<PB8QE%E3'4.83"(B8QA$1'/,1Q.4(0RWNM(0VD:)0A(2D#@+)
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M4S=O/0CF5I:HVC=RJYAI,)N&.Y+(QBIDX\Z6LT42?%*UP)B5O1'MPA<BCUN
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M2@C7>#;;ITN;7ZL TQ+_ .).3UN51[8_/>VPVKK=W,?(B.9@@KD6SJZ@UWI
M',3%0G*2@FJYP#F)GD&I5! ZZ(&=I3'N6V2B5%8LU7=G]:H;*AP][HM<IU80
MT3P!5$J$M: =5!EPI%D+M&HDK^)^SQF:CMD*>ROM8R[F>0B]R(&9,LU>@./
M6N4MSZ5 9<5^U*I#0593B JGKOS@7*M#8"Y21^FE:+I,^SW7)"#SCM7M .WT
MO;64<A^HZ#>>MQ.LJ=BS',)73JV]1"B4A6AR@[Y7C?P/,F<:&H;K%4J(SI22
MK@XU6&V8U=CMG0+7$K<-R:^ +MMUJ&%7Z4$Q?/DL9HR;L]S,D[\RAT=6SJO
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M-43GZ8A2,KDHTC:-%AD[D/.U"E/)0/V?Q_*JHJ5NVO;II]"J+;;JM26:!'2
M-PDRB/3/\3[%YD_=WJELPS9!C*<-]]64<^MS5MQ][4&/2,U4=YYE W0A_-DM
M2E$N( REBZ8=5=<;DEJX:IF%_625#T@_4(4>>HE9?:&EH$L@H(!SC'94H$<V
M$1'(K**;D "@3,=;R:BW3*'[2%(<4.@I;E7J;*2>"LUY+CRRRD7 "7JCT[@
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MC(=:2I:Z2)[;"B9 WK50TQ(T4YK&@ZH9ND(R64- U;"JE*+J(GJ>?+A&S39
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ML9;VH!=/WC_EC1<Q!&\JX2AL\$)L-H=HMF1]=VHN4;62;K-X6^NUJUM$M*$
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MW=GEC&%24WL!I]/7SQK(1',N6667\?3$?&A!ZL70DILH]=[]U_S;":)MWAX
M8/IK@Y/#C>UQY</A;"!T7\1\1Z&&FY]VO;D'GEG_ /E@6&M]/'3MU[?SAA$>
M'>&_Q ?H&#$GZ?\ A.O=8GEIRPWK&G=Z_/AAEJ?=GW#P_;K'P#=C"QK?K]?;
M"%:?W#Q'/M'PTPL0= 'JT\OVQE!XCQ]?#"-8X'P]?'"B)]0'/00[?'Z^08,P
M@=3:_8;<N!Z_AYG"R!^'5W_-V8>&#$GAY?3YV/\ UCVV;W$V\#\#Z'GAI!3(
M0'/0??KUZ]!\@P;Q%^8T\N'P\K:\<(W47OVZCOY\^?U[,5"V4 0#,=_OY?,^
MS&,,SZ+$GUV]??V7.%$#Y#EGJ&[?X?;RP8DWTZ[>?9VD"]^L=HN@=1<'J/S_
M "/KV8914 P!N^P]7CO#ZX]?=-^OB+<!U]?:..EQINX;'4$$GU;K/:.!^PPD
M@L)1R$?G7]PW:\,\&81N-WU'J_T/P[L52B#Z/*QD!0,1%V!SM%E4B+LGI43%
M!=+]95&SD$CB1-VV/SQ3,8$W"9#& N"2IE\NLA8*V[)=2E10ZT5 E"M"'&RH
M J;6+;P&\A1 O@E3,F)T,@M%+;H4ME:T)6R\$* <1J%-.I2HA+K9WMPG=<2"
M1>]5,4;1%RB$;4W6,!;RLS !1I*XLJ6$H^:<&RR+2MR'YCP\&=0XG_\ A=RW
M5/QL<V12-_F!.O'7X1O'YE5JE$)7-ILRL4T&_P#$:-']ZJ,5 YSZ*R!)E!(M
M_I%#;F//+41_!XC2.D7)(-!HF90E%,K%/R]656!I.8I0A4B8X3I_"\QODPX)
M42?]%S(Y3X\=M /\?G/N=$E^I]EG:1HU))Y.62N46*<I@NRJ.(I64J6DI) <
M^:XB:PII"7I>7;F !,5Q&2[M$Q1*<I^:8HB3 S_DNI%2(N:*)TZ"4N0Y$]B#
M4&%#BB13IJXT^,O4 I>CM*T(*20<#JVRG:/1T)>G9)S((CJ=]FH1*5)J5)DH
MULN+5Z:W+I<ILVT<CRW4%-E!1!!-.P-C[X5.[(PINSETZB>J' A&D);ZK95R
M8PB  4J#&(75$V8[LN/##E)S;E>"V79N9:!$:2+ER56*<P@"W$K=D-@#P/?U
M,T+(&=JH\(]-R;FFH/J(2&8.7ZM*=)/ !MF(M7_9Y'J..H+94V)Z\9TUR<<G
M7L"%/QVS=3-_+@5A"S9OPD^%P[MU%'RU'0:\.<GXINXIQ,1E7ZBX-P9.XAHQ
M4!5=90B=$MH&U*E.SMM3%(E>^/9WG91I%.E11TD3^#9=A/1ZE*1)!W%HFJM'
M92G>+C<AQT;J4))Z?;*MA]<8IOLW2J]!%/C;,Z9G_,%7A3OY50_Q'F^HQI='
M@N1%)Z5MRFI)EOJ7T?0O0V6%;RUJ2FW6WEM]TOL:4*OLO[-\HVE+TNOSM[6]
M9I?AW*=OY2L91_4M4SKSF HU<W*JB;FI.;)'B4[6FS2 /WJ('"-CE7?9-LCG
M;2ZJC/>=F'&,L(]U9I5,5O-JK#%,CLP8$1LJ*5MT.GQ(K$0O7#DX,]"TJW3O
M)8=O&WNF;&J$O9?LVE-RLZ/&<_6ZTGHW$T"7694BJ56>]N@LNYEJDZ;)G"/8
MM4TR.G>1<1HRN721DW\J^>2<H^=2$C(NW#Z0D'[E9V^?/7:QW#IX\=N#J+N7
M;E<ZBSAPLH=9=8YU%3F.8PC>]IMIAIIAAMMEAAM#++#*$-LLM-)"&VFFT!+;
M;:$)"6T)24H2 E(  QR]><?E/O2I3SLB3)><D29#[BWGY#[SBG'GGWG%*<=>
M=<4IQ;BU*4M:E*4HDDDLZP%S N_KX!Y_/0<"))]?/K\>'+&4-Z#D.9YG$BHK
MGF(CIQ'K[ [/@\<8P>E/(>NTX+<+Y /IV=H\?KGEV!CV%33=[6\^O\?VXXUK
M(CD;+373=K_&GKB/XNC+1J;=H[/'MOA%$W#P\]0]<&(/Q'Q'5X6\L-2Q<'LU
M]>&&&Y]V_P!O;K$!\\&8;GD\?'ER/#R/QPTB;=Y>(;O3UP))]:\.!X=FM^S#
M8L:D'GU^M,*H'R$.W4._J'V\\#4+I[1Q\./W[1;")Q)!OU:'Z'UV8;2, @':
M&7B&[S]\%@V(/5A&M.I'7J/78<(('_V\0U#Y\ -,'\<(G$]?<?7KEA5$^X>K
M0>[RX9>.7;@23K;K^?YN1V7ORP@=3Q[-#W'AZ[>S"Z"G#< ^@]_KW9]F#4FX
M\+'[^N8(PB6GB/$'U\<.-5LL@'L =./#MRX#OT[<9.F&Y]N]SZ%N/'\:7&'$
MS\X 'B'SYUAC(-OKZ^7;AJ6BQ((T/P]<L)(+9?4!X]W;[^>1@_5WV[KCY@\+
M]1L1H=43K5^_D>O\]8_&*NI]DQF'98]U+M859R %8/Y$%"Q(.<QYK:3<HD56
MCTG #T:4B*"[5LXZ(LB#5@JYDV":2^[&;+S<=R2A!)=:9W3("+7*V&U%*75(
M_<MC?0M:-Y3'2.!##I<6&Q)=+#LIN&MS1EZ0%")TG)$AQ 4J.AS]J9!0MIM>
MZ) :84Y(8NHV<W LK)%BJMI!H[@YY!"15I>LXT\M1-:10B=)M.0<E'/$"NVZ
MZ)ET(FO+?U$RE$F;ER$!4Z"#M<56E0I.9F2_3ZBXW*B+4RF=3'A'J=-?T4N+
M*8>;66UI4$JD4JKPW6%.(1[U!4IM 2Z[M<RA($:ITEIZ#.0B0NEU>.95&J\;
M5+<R'(CO-AUM:"I,6MT*>Q*0TXX(510V\YO7F@(G8_N04AGE?7)V;)Y3(SAI
M4%*_YVVU,J.BAF%0TNXINXM/LN>//;1CVBJ]>-D/]%S4DBN3\0LPR9>T6C$A
MNDT7.L0:(<AS_P##%;"1PZ:'.1-H\MRVBWFJE2FUK_4B&TD[B7R+3-DN8=TN
MUW,6SF<K5QJ?2_\ &>6U+/[O=Y],<IV8(#-_U-QWZ16W6VQN.3Y"QTB\I[3V
M8?T&I^86@Y4ZPUN(UPH"ZBD'<V]=MI%P4P!^I]3BU'09ESF*  HW>F.!@_0H
M(AIB#U_,[563T68M@^:JT^A)2!*HF6JTR@B^C4U-0E!(!U2MH \T\,;&RQDI
M^@GI\I>T_DC+L9:@M1A9CSCEQ]R^MWJ>JE0RM1 &\VZ57_:K&V[9:M;7]Y))
M%I*<IQM#7LB&:APE@L; 5E2M&LC-2"=1I(7SG6+^&<*KF*5 T1%G95,J105F
M1"%*L\:5^SU7J1EQE3C&P_)^6)+@'N_^*9=.GU)P+-@XSE:*ZS(0E )6),A+
ML$%(2Z22AMRU>S+*U?S?);;E>TKM SG#:)$H9)@5:ET=HM J4U(SM-8D1%J<
M("#&C*8J2TDJ9  4\U47*;<IQ&[.D9)6$L1+MY2^+UB#&I*G2<%DFUIH]RW
MI>D77.X!_<%VV.55DT=&7"#34)+S *.E&3)TCV(;$'LY/LYLS7'6QE9I[I84
M%2.A7F!Y"[FR4A!9I#:P4NNH"?>E QHUD!UUM=[2GM)L;/8LC(F1I:).=GV
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MXY4A:$.J80TI2%H0HE"@)"$K_8)V]H9_3\9.;/VT<W*R.=]3D@E350U1%,S
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M'L9ZH;)6"IAP4S:*9R\M0EK(%<B(%*9O'MWKB"CU2I <A3)-B&!,#% 2AS@
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M,.+_ .W+M8[4R9&U^K\5Y<&(2<$=I4PY?MX.BTGJ1N<D]3HBEVD+2!'R(_\
MR7A(4'2)1$B:I"B)<3G+>0LG91)7EW+U.IKQ24&6AM4B<6S^YLSY:Y$TMJ_J
M;+^X>)23B!YESQG+-P",PYAJ-292H+$5;B(\#?!NEP4^(B-"#B?Z7!'"P- H
M#&+0+]O_ +OH.6)?<]GD/MB'%H]M^[3X?<XJVB;AUM;6I8VL[=UC4]"5=#*B
MM$U11\[)4W4$:J8.:<[*7AW3-^V%0@B10$ER@HF)DU ,0PE%%/IT"JQ'8-3A
M1*C"?&Z]$G1VI49T W <8?0MM=CJ-Y)L;$6(OA7 F5*E2FIU,F2Z?-8.\S+A
M2'HLEH\"6WF%(<3<:&RA<7!N#;&R^EN6^Y3"E(M*(;[1ZLVU;I DW6JJW%J*
MBDTRE+S0.K-2-$K3#]4<@$5)-\].8V9A,(B;G:KF;!=E4QTO*RPF.M1)4F'5
M*Q%:-S>P8:GAAL=0:;; &G #&U8>W;:O#:# S.J0A( 2J72J1*> &FK[L O.
M'_:><<-_'&+FT/M][7VU8T+%7ZOS6M<T^1PF["DB*1E+42=V@<#MG:]%T9&4
M]2SIXT,&;1ZZB%W;;,XHKD$YQ-+,L[.\E9/7TV7<O0:?)*2CWTAZ7/"%"RD)
MGSG9,M"%C][:'DH5IO)-A:*9FS]G?.".AS#F*?/B[P7[D"S$@;Z3="U08+<6
M(M:#^Q:V5.(ULH$DG$ 7 =8>&6OJ/MB:7)XF^(<&=>_EJ;?#CXXVM\E[R8=Q
M]ORXS6;FFDO2&S51\NB6X]Q@2%LK.+-NC<JT#0*CE,4I&J9%$R1)&132<QU'
M1SDLK*@L^7A(2;T_M8VL4S9W3%L1ULS<TS65?PRF;V^(Z5W0*C40DW:B-*!+
M31*'9KJ2TSNMI??8V_LIV2U':!4D/R$/P\L0G@*E4@G<4^I-EJI]/4L*#DMU
M)2'70%-PFUAUT*6IAA[T$**HNE;<TA3- T-!1U,4;1L'&TW3%/1* -XZ&A(=
MHDRCH]HD B()-VR*9 .H8ZJI@,JLHHJ<YS<XITZ94YLJHU"0[+G3I#LJ7)>5
MO.OR'UEQUU:M/U+6HFP  X)   '1:#!B4R'%I\".U$A0F&HL6,RG=:8890&V
MFT)_RI0D"Y))XJ)))/D3 .6.J*3Y\_\ :'U(\R.>((XV%@Z>NL?7K[\1BFS^
M?-??>'$ &#;4<..GS'U'/ON"S28UKD#UZ]#^F,F<2"'4/SYQX\=3@H*U%K_
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?9C18S2&6&6T\$-MH"4I%R2;"Y42HW4235&$F%6/_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
